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ABSTRACT
Pulsatile gonadotropin-releasing hormone (GnRH) release is essential to 
fertility and is modulated by gonadal steroids, most likely via steroid-sensitive 
afferents. Arcuate neurons coexpressing kisspeptin, neurokinin B (NKB), and 
dynorphin (KNDy neurons) are steroid-sensitive and have been postulated to 
both generate GnRH pulses and mediate steroid feedback on pulse frequency. 
KNDy neurons have been proposed to interact with one another via NKB and 
dynorphin to activate and inhibit the KNDy network, respectively, and thus alter 
kisspeptin output to GnRH neurons. To test the roles of NKB and dynorphin on 
KNDy neurons and the steroid sensitivity of these actions, targeted extracellular 
recordings were made of fluorescence-identified neurons from male mice that 
were either gonad-intact or castrate and otherwise untreated or treated in vivo 
with steroid receptor agonists. Senktide, an agonist for the high-affinity receptor 
for NKB (neurokinin-3 receptor, NK3R), increased action potential firing in KNDy 
neurons. Dynorphin reduced spontaneous KNDy neuron activity, but antagonism 
of kappa-opioid receptors (KOR) failed to induce firing in quiescent KNDy 
neurons. Senktide-induced activation was greater in KNDy neurons from castrate 
mice, whereas dynorphin-induced suppression was greater in those from intact 
mice. Similar to the intact condition, both estradiol and dihydrotestosterone 
suppressed NK3R agonist-induced KNDy neuron firing and enhanced the 
inhibition of firing rate caused by KOR activation. An estrogen receptor-alpha 
 xvii  
agonist but not an estrogen receptor-beta agonist mimicked the effects of 
estradiol on NK3R activation. These observations support stimulation and 
inhibition of KNDy neuron firing by NK3R and KOR activation, respectively. 
Modulation of these responses by gonadal steroids may be a mechanism 
mediating steroid negative feedback. Overall, the work presented here supports 
contribution of KNDy neurons to steroid-sensitive elements of a GnRH pulse 
generator.
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CHAPTER 1 
Introduction 
 
A note from the author: The Introduction (Chapter 1) of this dissertation 
reviews the state of relevant knowledge in the field at the initiation of the 
dissertation (in 2011), while the Conclusion (Chapter 4) integrates the present 
work with data from more recent publications.
 
1.1 Significance 
Reproductive health is vital to individual quality of life as well as overall 
species survival. The reproductive system is responsible for proliferation of 
organisms via puberty onset, ovarian cyclicity, gametogenesis, fertilization, 
pregnancy, and lactation. Up to 20% of couples are infertile, and the cause in 
~20% of these cases is unexplained (1), demonstrating the importance of 
continued research in normal reproductive physiology and pathophysiology. 
Beyond reproduction, sex hormones impact other systems, including the 
nervous, skeletal, and cardiovascular systems. 
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1.2 The HPG axis and GnRH neurons 
Complex networks in the central nervous system regulate fertility. The final 
common pathway that integrates the output of all of these networks is the 
gonadotropin-releasing hormone (GnRH) neuronal population, which is located in 
the preoptic area (POA) of the hypothalamus and has projections to the median 
eminence (2). At the median eminence, GnRH neurons release GnRH into the 
hypothalamo-pituitary portal vasculature to stimulate the pituitary to release 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (3-5). LH and 
FSH initiate gonadal production of testosterone, estradiol, and progesterone, and 
these steroids feed back to regulate GnRH output and the pituitary via androgen, 
estrogen, and progesterone receptors (6-8). However, GnRH neurons 
themselves have only been rarely shown to express progesterone receptors, and 
have not been shown to express androgen receptors, or the α-isoform of the 
estrogen receptor (ERα, Figure 1.1 A), which is more critical for estradiol 
feedback than the β-type estrogen receptors expressed by GnRH neurons (9-
17). These data implicate a critical role for steroid-sensitive afferents to mediate 
feedback to GnRH neurons, but knowledge of the identity and function of such 
inputs is incomplete. Understanding how steroids regulate these inputs will 
enhance our basic knowledge of normal neuroendocrine function and can help 
develop more effective strategies for the diagnosis, management, and prevention 
of central conditions that compromise fertility.
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Figure 1.1 ERα is not detected in most GnRH neurons but is present on most kisspeptin 
neurons. A: Micrograph (x 400) of the lack of immunohistochemical colocalization of GnRH 
(brown cytoplasm) and ERα (black nuclei) in the organum vaculosum of the lamina terminalis of 
an ovariectomized female rat (13). B and C: Photomicrographs showing coexpression of Kiss1 
(red) and ERα (silver grains) mRNA in brains from female (B (18)) and male (C (19)) mice. Scale 
bar = 20µm. 
 
 
Figure 1.2 The hypothalamo-pituitary-
gonadal axis. The mechanisms for gonadal 
steroid feedback in the brain are not well-
understood.
 
Patterns of GnRH release 
One crucial way that steroid feedback affects GnRH is by modulating its 
pattern of release. Normal GnRH release can be described in two fundamental 
patterns, pulses and surges (4,20-24), both of which are critical to reproduction. 
While the GnRH surge is only observed in females prior to ovulation, GnRH 
pulses are prevalent throughout the remainder of the female cycle and regularly 
in males. GnRH/LH pulses can be too frequent, as in polycystic ovary syndrome 
A C B 
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(25,26), too infrequent, as in hypogonadotropic hypogonadism (27), or can begin 
too early, as in precocious puberty (28). All of these can cause infertility and 
associate with other long-term health problems that have a profound impact on 
quality-of-life. 
In a test of the importance of GnRH pulses, hourly treatments, but not 
constant treatment, with GnRH maintained effective concentrations of circulating 
LH and FSH in ovariectomized monkeys with ablations of the mediobasal 
hypothalamus (MBH; Figure 1.3) (29). The ablations presumably interfered with 
the release of endogenous GnRH because they abolished LH and FSH release 
(29). Similar observations have been made with gonadotropin-specific subunit 
expression in vivo in ewes and rats and in vitro with cultured rat pituitary cells 
(30-36), suggesting that the pattern of GnRH release is critical for healthy release 
of gonadotropins. 
While both LH and FSH require pulsatile GnRH secretion, specific GnRH 
patterns differentially regulate each gonadotropin. A higher GnRH pulse 
frequency favors pituitary expression and release of LH, while a lower GnRH 
pulse frequency favors pituitary expression and release of FSH (33-36). Although 
GnRH pulses influence the release of both gonadotropins, LH release requires 
GnRH pulses, whereas FSH can be released constitutively (37,38). Therefore, 
LH but not FSH is commonly used as an indicator for GnRH release (5). 
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Figure 1.3 Suppression of plasma gonadotropin concentrations by continuous GnRH infusion in 
an ovariectomized monkey with lesioned hypothalamus. The levels of gonadotropins sustained by 
pulsatile (1 µg/min for 6 min once per hour) GnRH infusion were suppressed by continuous 
infusion of GnRH at the same rate (1 µg/min continuously) between days 0 and 20. Gonadotropin 
levels were recovered by re-establishing GnRH pulses beginning day 20. Dark circles = LH, open 
circles = FSH. (29) 
 
Gonadal steroid regulation on patterns of GnRH release 
In correspondence with the two patterns of GnRH release, gonadal steroid 
feedback also has two modes, negative and positive. In both males and females, 
negative gonadal steroid feedback corresponds with pulsatile GnRH release. In 
females only, positive steroid feedback is associated with the GnRH surge. The 
female reproductive cycle is known as the menstrual cycle in some mammals, 
including primates, and the estrous cycle in others, such as sheep and rodents. 
From mid-follicular phase, estradiol rises and becomes predominant, and, in 
sheep, there is roughly one GnRH pulse per hour (39). The amplitude of these 
pulses is inhibited by estradiol (40). Towards the end of the follicular phase the 
ovary produces substantially more estradiol, resulting in lower-amplitude GnRH 
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pulses that progressively increase in frequency until the mode of estradiol 
feedback switches from negative to positive (39,41,42). At this point, estradiol 
positive feedback causes a sudden high-concentration surge of GnRH (23,39), 
which causes a subsequent surge of LH that induces ovulation (23,39,43). 
Ovulation marks the beginning of the luteal phase, during which steroid negative 
feedback resumes. During this phase, estradiol is still present, but progesterone 
from the corpus luteum becomes dominant (44). The frequency of GnRH pulses 
during the follicular phase is reduced by progesterone to about one pulse every 
four hours (39,40,44). In the absence of pregnancy, progesterone and estrogen 
levels decrease, resulting in sloughing of the uterine endometrium, manifesting 
as menstruation in those species that have a menstrual cycle, and beginning the 
follicular phase of a new reproductive cycle (44). Similar steroid feedback on 
GnRH occurs in species such as mice that have estrous cycles, with positive 
steroid feedback happening during early proestrus and negative feedback 
occurring during the remainder of the cycle. Because of the vital nature of 
gonadal steroid feedback to GnRH, studying the mechanisms that may mediate 
this feedback is crucial to enhancing our understanding of reproductive function. 
 
 
1.3 Kisspeptin 
One candidate that has emerged as a potential mediator of gonadal 
steroid feedback onto GnRH neurons is the neuropeptide kisspeptin. Kisspeptin 
appears to be a key regulator of reproductive function. Mutations in the 
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kisspeptin receptor KISS1R can cause hypogonadotropic hypogonadism in 
humans (45,46), and knockout of the genes for kisspeptin (Kiss1) or its receptor 
(Kiss1r) reduces or eliminates reproductive function in mice (47,48), suggesting 
that kisspeptin plays a stimulatory role in the reproductive axis. Conversely, an 
activating mutation in KISS1R can lead to precocious puberty in humans (49). 
Consistent with these observations, the castration-induced rise in LH can be 
blocked by kisspeptin antagonists in the male rat and mouse (50), supporting 
kisspeptin as an intermediary to gonadal steroid feedback on gonadotropin 
release. 
There is functional and anatomical evidence that GnRH neurons receive 
kisspeptin signals both directly and indirectly. Functionally, kisspeptin depolarizes 
and increases action potential firing in GnRH neurons in vitro and ex vivo (51-
57), and it stimulates GnRH release in the median eminence in vitro and in vivo 
(3,58) (Figures 1.4 and 1.5). In rodents, higher Kiss1 mRNA expression in the 
hypothalamic arcuate nucleus accompanies increased secretion of GnRH and 
gonadotropins, and these effects are blocked by knockout of the kisspeptin 
receptor gene (Kiss1r) (19,59). 
 
 
Figure 1.4 Kisspeptin stimulates GnRH neuron action current firing. Extracellular 
electrophysiological recording from a GnRH neuron ex vivo in a brain slice preparation from an 
ovariectomized (OVX) adult mouse. 1) Currents recorded during an untreated control period. 2) 
Currents recorded during treatment with kisspeptin. Each vertical line is a trace of the current that 
corresponds to an action potential. (55) 
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Figure 1.5 Kisspeptin stimulates GnRH 
(LHRH) release in the median 
eminence. Perfusion through a dialysis 
membrane with 10nM of human 
kisspeptin-10 (kiss-10, second gray bar) 
markedly increases the levels of GnRH 
collected by microdialysis from the 
median eminence of a pubertal female 
monkey and measured by 
radioimmunoassay. (58)
 
Anatomically, the majority of GnRH neurons in mice, rats, and sheep 
express Kiss1r message or protein (Figure 1.6) (53,60-63), and Kiss1r mRNA 
has been found in both the MBH and POA of monkeys (64,65). Furthermore, 
kisspeptin neuron fibers have been found in apposition to GnRH neurons in 
rodents, ungulates (large, hoofed mammals including goats, pigs, sheep, and 
horses), and primates (Figure 1.7) (62,66-74), supporting direct action on GnRH 
neuronal cell bodies and/or projections. Kisspeptin may also signal GnRH 
neurons via indirect pathways, including GABAergic or glutamatergic 
interneurons (55,75) or nonsynaptic communication in the median eminence, 
such as paracrine action via portal capillaries (68-70,72,76). 
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Figure 1.6 Photomicrograph 
showing coexpression of GnRH 
(red) and Kiss1r (silver grains) 
mRNA in adult male rats. The 
majority (77 ± 2%) of all GnRH 
neurons coexpress Kiss1r. Arrows 
= GnRH neurons that coexpress 
Kiss1r; scale bar = 20 µm (61) 
 
 
Figure 1.7 GnRH (green) neurons and 
kisspeptin (red) neuronal fibers are 
apposed in adult female mice. A: 
Confocal stack of 75 images. a, b, and 
c: individual 370-nm thick optical 
sections of the regions indicated by the 
corresponding letters in panel A. Scale 
bar = 10 µm. (66) 
 
Kisspeptin neurons 
Kisspeptin likely originates from neurons in several locations throughout 
the brain. In rodents, kisspeptin-expressing (message and peptide) neurons have 
been found in the hypothalamic arcuate nucleus, anteroventral periventricular 
 10  
nucleus (AVPV), periventricular nucleus (PeN), anterodorsal preoptic nucleus, 
paraventricular nuclei, ventromedial hypothalamic nucleus, posterior 
hypothalamus, caudoventrolateral reticular nucleus, lateral reticular nucleus, 
hippocampal dentate gyrus, medial amygdala, bed nucleus of the stria terminalis, 
nucleus of the solitary tract, spinal trigeminal tract, and cerebral cortex (66,67,77-
84). In ungulates, Kiss1-expressing somata have also been found in the arcuate 
nucleus, PeN, dorsomedial hypothalamus, medial preoptic area (mPOA), 
ventromedial hypothalamic nucleus, caudal paraventricular nucleus, and preoptic 
periventricular zone of the hypothalamus adjacent to the third ventricle (68-
70,85). The population of kisspeptin neurons that appears to be most highly 
conserved in primates including humans is in the infundibulum, the analog of the 
arcuate nucleus (64,72,86). Otherwise, humans only have a sparse distribution of 
kisspeptin cell bodies in the mPOA and do not appear to have any kisspeptin 
neurons in the rostral periventricular region of the third ventricle, and rhesus 
macaques do not show any kisspeptin neurons in the POA, including the AVPV 
(64,72,86). 
In rodents, the kisspeptin neuron populations that appear to be most 
directly involved in reproduction are those in the arcuate nucleus and the 
AVPV/PeN. Both populations extend projections to GnRH neurons (87), and both 
express gonadal steroid receptors (Figure 1.1) (18,19,88,89). Kisspeptin 
expression in both of these regions is affected by gonadal steroid feedback 
(18,19). However, the effects of gonadal steroids on kisspeptin neurons may 
differ between the arcuate vs AVPV, as supported by both anatomical and 
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functional evidence. While the number of kisspeptin neurons in the arcuate 
nucleus appears to be similar between males and females, the number of 
kisspeptin neurons in the AVPV is 10 to 25 times higher in female rodents than in 
the same region of male rodents (66,80). This sexual dimorphism in kisspeptin 
expression in the AVPV but not the arcuate mirrors the differentiation in positive 
but not negative gonadal steroid feedback. Functionally, ovariectomy increases 
and estradiol treatment restores low Kiss1 mRNA expression in the arcuate 
nucleus of female mice and rats, whereas these treatments have the opposite 
effect on Kiss1 in the murine AVPV (Figure 1.8) (18,19,90). In intact female rats, 
Kiss1 mRNA levels are their lowest in the arcuate nucleus and their highest in 
the AVPV during the preovulatory estradiol surge (91), consistent with negative 
estradiol feedback in the arcuate and positive feedback in the AVPV. These 
distinctions are further reflected by intracellular signaling mechanisms initiated by 
activation of ERα. Negative estradiol feedback on serum LH concentration via 
ERα is mediated by “non-classical” signaling that is independent of the estrogen 
response element (ERE) (92). Similarly, estradiol inhibition of Kiss1 expression in 
the arcuate nucleus is also mediated by ERE-independent mechanisms (92,93). 
In contrast, positive estradiol feedback on both LH release and AVPV Kiss1 gene 
expression utilize “classical,” ERE-dependent ERα pathways (92,93). 
Interestingly, both positive and negative estradiol-mediated feedback on 
spontaneous action potential firing rate of GnRH neurons requires ERE-
dependent ERα signaling (94), suggesting GnRH neuron firing uses different 
signaling mechanisms for ERα-mediated negative feedback than arcuate 
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kisspeptin neurons or the pituitary. GnRH neuron ERE-dependence 
notwithstanding, these observations support overall separate roles of arcuate 
kisspeptin neurons in negative estradiol feedback and AVPV kisspeptin neurons 
in positive estradiol feedback. 
 
 
Figure 1.8 Photomicrographs of cells in the arcuate nucleus (Arc, top) or AVPV (bottom) 
expressing Kiss1 mRNA (white clusters of silver grains) from female mice that are intact (left), 
ovariectomized (OVX, middle), or ovariectomized and estradiol-treated (OVX+E2, right). Estradiol 
inhibits Kiss1 expression in the arcuate nucleus, and stimulates Kiss1 expression in the AVPV. 
3V = third ventricle; Scale bars = 100µm. (18) 
 
Support for negative gonadal steroid feedback on arcuate kisspeptin 
neurons has also been observed in models other than female rodents. In male 
mice, rats, hamsters, and monkeys, castration increases Kiss1 mRNA in the 
MBH (which contains the arcuate/infundibulum), whereas replacement with 
estradiol, dihydrotestosterone (DHT), or testosterone restores lower Kiss1 mRNA 
(19,61,64,81,90). Estradiol replacement has also been found to inhibit 
ovariectomy-enhanced Kiss1 expression in sheep and monkeys (73,86,95). 
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Similarly, KISS mRNA is increased in the infundibulum of postmenopausal 
women, in whom estradiol levels are low (86). 
All kisspeptin neuron populations and their potential roles, especially in 
reproduction, must be acknowledged when interpreting observations about 
kisspeptin’s influence on GnRH/LH release. However, this dissertation 
investigates negative gonadal steroid feedback and potential mechanisms 
affecting GnRH pulsatility in adult male mice. Therefore kisspeptin neurons in the 
arcuate nucleus will be the focus of the remainder of the work presented here. 
 
 
1.4 GnRH pulse generator 
The mediator of gonadal steroid feedback onto GnRH pulses may or may 
not be the same as the originator of the GnRH pulses. The concept that a 
steroid-sensitive originator of pulses may be located in the central nervous 
system was first proposed after a study that took frequent blood samples from 
female monkeys. This study observed a peak (pulse) in LH concentration roughly 
once per hour in ovariectomized monkeys, and these peaks were suppressed in 
intact animals (20), suggesting gonadal steroid feedback. In addition, the 
fluctuation in concentration that occurred with LH was not observed with another 
pituitary hormone (20), suggesting that there was not a broad, nonspecific effect 
on pituitary hormone release. The term “GnRH pulse generator” emerged to 
describe the possible brain unit that initiates GnRH pulses when researchers 
performed studies recording in vivo electrical activity, referred to as multi-unit 
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activity (MUA), using an array of multiple electrodes implanted into the brain. 
MUA recorded in the MBH of monkeys (Figure 1.9) (96-98), rats (99), and goats 
(100-102) consistently correlates with circulating LH pulses. Adding to these 
observations, lesions of the arcuate nucleus within the MBH block LH pulses in 
rats, while complete deafferentiation of the entire hypothalamus does not affect 
LH pulsatility (103). These data suggest that the MBH and, more specifically, the 
arcuate nucleus is a critical source of GnRH pulse generation that can function 
independently of extra-hypothalamic inputs. Importantly, this same anatomical 
region may be responsible for both pulse generation and steroid feedback. MUA 
in the MBH is also sensitive to gonadal steroids (104-107), and site-specific 
gonadal steroid antagonism demonstrates that the arcuate nucleus is a region 
critical for steroid feedback on LH pulses (108). Together, these data are 
consistent with a GnRH pulse generator in the arcuate nucleus that is also 
steroid-sensitive. 
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Figure 1.9 Correlation between peaks of multi-unit electrical activity (MUA) and LH pulses in an 
ovariectomized monkey treated with thiopental anesthesia. Top plot indicates LH levels in 
peripheral circulation (open circles), bottom plot indicates MUA in the arcuate nucleus. (97) 
 
Within the arcuate nucleus, kisspeptin neurons may be key contributors to 
the GnRH pulse generator. Not only is Kiss1 mRNA expression steroid-sensitive, 
as outlined above, but pulsatile release of kisspeptin in female rhesus monkeys 
correlates with most GnRH pulses (58). Similar to GnRH, it appears the pattern 
of kisspeptin release is critical. Pulsatile treatment with kisspeptin maintains LH 
pulses in male rats and monkeys (109,110), whereas continuous kisspeptin 
decreases LH secretion in castrate male monkeys and testicular degeneration in 
male rats (111-113). It should be noted that some low-concentration GnRH 
release and low-amplitude LH pulses are possible with mutations in kisspeptin or 
its receptor, resulting in sub-optimal but present reproductive maturation 
(46,114). However, kisspeptin signaling is required for normal regulation of 
 16  
GnRH neuron activity (measured by cFos)(89) and pulsatile LH release (59,115), 
supporting the importance of this peptide in healthy reproductive function. 
 
 
1.5 KNDy neuropeptides and the KNDy neuron working hypothesis 
In addition to their putative role in negative gonadal steroid feedback on 
GnRH pulse generation, arcuate kisspeptin neurons are unique for their co-
localization of neurokinin B (NKB) and dynorphin (102,116-121), two other 
neuropeptides that have been implicated in reproductive function. Mutations in a 
high-affinity receptor for NKB (neurokinin-3 receptor, NK3R), or NKB itself result 
in hypogonadotropic hypogonadism in humans (122,123), thus NKB may be 
stimulatory. In contrast, LH release is increased by antagonists for the κ-opioid 
receptor (KOR), which binds dynorphin (45,46,122,124), suggesting that 
dynorphin is inhibitory. Similar to their effects on expression of kisspeptin, 
gonadal steroids also inhibit expression of mRNA for NKB and dynorphin 
(93,120,125,126), and both NKB- and dynorphin-expressing arcuate neurons 
have been shown to express gonadal steroid receptors in single and dual label 
studies (88,119,127,128). Projections singly-labeled for neurokinin B or 
dynorphin have been located near GnRH somata and/or processes 
(118,129,130), and dual-labeling studies in sheep and rats have also shown co-
localization of KNDy neuropeptides in projections apposed to GnRH neurons 
(121,131), supporting the arcuate kisspeptin population as the origin of these 
projections. 
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Arcuate kisspeptin neurons may act on each other, as well. Not only do 
these neurons express NK3R and KOR (120,130,132), but arcuate cells with 
NKB and/or dynorphin appear to have projections in apposition to or directly 
synapsing on each other (119,128,130). Interestingly, kisspeptin receptor 
expression has not been found in the arcuate nucleus (63), suggesting that while 
NKB and dynorphin may act on these putatively interconnected neurons, 
kisspeptin may not. 
To reflect the key roles these peptides appear to play in reproduction, the 
Goodman lab has proposed that the arcuate kisspeptin-, NKB-, dynorphin-
expressing neurons be renamed “KNDy neurons” (133). This alternative name 
can be used interchangeably with “arcuate kisspeptin neurons” and will be used 
from this point on to describe this neuronal population. KNDy neurons are 
hypothesized to contribute to GnRH pulse generation in the following model 
(Figure 1.10) (117,120,131,134): They are proposed to act in a network that 
projects both to GnRH neurons and to other KNDy neurons. In this network, NKB 
acts on NK3R on KNDy neurons to stimulate and synchronize these cells and 
cause kisspeptin release, which increases GnRH neuron activity. Dynorphin then 
acts on KOR to inhibit KNDy neuron activity, which would decrease release of 
NKB and kisspeptin, and thus GnRH. Communication among KNDy neurons may 
also be mediated by fast synaptic transmission, as the vesicular glutamate 
transporter vGluT2 and glutamic acid decarboxylase GAD-67 are coexpressed 
with KNDy neuropeptides in arcuate neuron cell bodies and terminals (131,135). 
 18  
To better understand KNDy neurons in the context of central control of 
reproduction, it is critical to understand what we know about NKB and dynorphin. 
 
 
Figure 1.10 KNDy working model. KNDy neurons are located in the arcuate nucleus and are 
hypothesized to mediate negative gonadal steroid feedback onto GnRH neurons through 
modulations of their neuropeptidergic output (more details in text). +, stimulatory; -, inhibitory. 
NKB, neurokinin B; DYN, dynorphin; KNDy neuron, neuron that colocalizes kisspeptin, NKB, and 
DYN; GnRH, gonadotropin releasing hormone; NK3R, neurokinin-3 receptor; KOR, κ-opioid 
receptor. 
 
Neurokinin B 
In many mammalian species, NKB appears to be stimulatory to GnRH 
release. For example, NK3R agonists increase both LH secretion and MBH 
electrical activity in ewes and goats, respectively (102,136). The NK3R-enhanced 
LH secretion is also observed in castrate male monkeys, and it is blunted by 
kisspeptin receptor desensitization, suggesting that action of NKB is upstream of 
kisspeptin in this model (137). In rodents, the role of NKB is less clear because 
stimulation of NK3R enhances, inhibits, or has no effect on LH secretion in rats 
and mice (120,125,138,139). A possible explanation for the disparity between the 
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results of the rodent studies compared with those from other mammals is that, in 
testing responses to NK3R activation, the rodent work only measures pituitary 
output. Despite the importance of LH, measuring it does not necessarily reflect 
central actions of NK3R. In this regard, NKB may act at various loci upstream of 
the pituitary. This is hinted by an increase in expression of cFos (an immediate 
early gene associated with increased firing activity) in arcuate kisspeptin neurons 
from female rats when treated with the NK3R agonist senktide (125). In addition 
to its action on KNDy neurons, NKB may also influence GnRH neurons. Despite 
observation of little to no NK3R on GnRH neuron cell bodies in sheep and rats 
(121,132,140), NK3R immunoreactivity has been found in apposition to GnRH 
nerve fibers in the rat median eminence (121,140), suggesting that NKB may still 
ultimately influence peptide release from GnRH neurons. 
 
Dynorphin 
Endogenous opioid peptides (EOPs) appear to mediate steroid negative 
feedback on GnRH secretion. EOPs are linked to progesterone negative 
feedback on LH release in human studies (141,142), and EOP receptor 
antagonists increase LH pulse frequency in intact luteal phase monkeys (143) 
and ewes (144) and pregnant rats (145), as well as ovariectomized and 
ovariectomized, steroid-treated ewes (144,146,147). These data support EOP 
inhibition of LH pulses. At the hypothalamic level, EOP receptor antagonism also 
increases the frequency of peaks of electrical activity in the MBH of 
ovariectomized rats (148) and increases both the amplitude and duration of each 
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GnRH pulse in ovariectomized ewes (149), supporting EOP action at the 
hypothalamus that can also act independently from gonadal steroids. 
Furthermore, EOPs appear to decrease the frequency of hypothalamic electrical 
volleys. Treatment with morphine, which can act via multiple opioid receptors (δ, 
µ, and κ) decreases the frequency of MBH MUA associated with LH pulses in 
monkeys (150), while treatment with the opioid receptor antagonist naloxone 
increases MUA frequency in rats (99,148), further corroborating a potential 
inhibitory action of EOPs on the putative GnRH pulse generator. 
In most mammalian species, the specific EOP involved in steroid negative 
feedback seems to be dynorphin (124,151), and its relevant action appears to be 
localized to the arcuate nucleus (151). Preprodynorphin mRNA is decreased in 
the arcuate nucleus of ewes and the infundibulum of women by ovariectomy and 
menopause, respectively (151,152). Intracerebroventricular injection of dynorphin 
in goats inhibits the frequencies of both LH pulses and MUA peaks, whereas a 
KOR antagonist increases these frequencies (102). When tested more locally, 
KOR-specific antagonist treatment targeted to the MBH of ewes increases LH 
secretion during the luteal phase, when progesterone feedback is prevalent 
(124). This outcome is not replicable with antagonists specific to other EOP 
receptors (124), supporting a dynorphin-specific effect. At the cellular level, 
expression of KOR message is found on almost all KNDy but no GnRH neurons 
(120,153). These data support arcuate dynorphin as a major mediator of gonadal 
steroid negative feedback, at least in primates, goats, and sheep. 
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The role of EOPs in rodents is less clear. Pharmacologically, KOR-specific 
agonism in mice inhibits an ovariectomy-induced LH rise (120), and KOR 
antagonism in rats stimulates LH release (154), supporting an inhibitory role of 
dynorphin. However, knockout of KOR decreases LH secretion (120), and 
ovarian steroids inhibit preprodynorphin mRNA expression in ovariectomized 
mice (120) in an apparent contradiction of results. Much like the rodent NK3R 
studies, though, these KOR-specific studies do not directly test a functional 
response at the level of the brain, leaving an incomplete picture of dynorphin’s 
hypothalamic actions in rodents. It should be noted that one study that did take 
direct measurements from hypothalamic neurons supports another opioid 
receptor as influencing GnRH output. GnRH neurons from guinea pigs are 
hyperpolarized by agonism of the µ-opioid receptor (155), suggesting that 
multiple EOP receptors may be involved with regulation of GnRH in rodents. 
Together, the data discussed here provide mixed evidence for stimulation by 
NKB on GnRH pulse generation and inhibition by dynorphin. Studies of the 
actions of these peptides at the level of the KNDy neuron may help to clarify their 
roles in pulse generation and gonadal steroid feedback. 
 
 
1.6 Dissertation project preview 
Before the studies presented in this dissertation, most of the data on 
KNDy neurons as the putative pulse generator had tested mechanisms either up- 
or downstream of KNDy neurons. There had been no direct tests of KNDy 
 22  
neuron function, particularly regarding modulation of their electrophysiological 
activity. Chapter 2 investigates how activation of NK3R and KOR affects KNDy 
neuron action potential firing and whether the responses to activation of these 
receptors are modulated by gonadal secretions in male mice. Chapter 3 expands 
these observations to test which specific gonadal steroids and gonadal steroid 
receptors are active in the responses observed in Chapter 2. Together these 
studies provide insight into potential mechanisms for negative gonadal steroid 
feedback on a potential contributor to the GnRH pulse generator.
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CHAPTER 2 
Regulation of arcuate neurons coexpressing kisspeptin, neurokinin B, and 
dynorphin by modulators of neurokinin 3 and κ-opioid receptors in adult male 
mice
 
The work in this chapter was originally published in 2013 in the journal 
Endocrinology (154:2761-71) 
 
Kristen A. Ruka, Laura L. Burger, and Suzanne M. Moenter 
 
2.1 Abstract 
Pulsatile GnRH release is essential to fertility and is modulated by gonadal 
steroids, most likely via steroid-sensitive afferents. Arcuate neurons 
coexpressing kisspeptin, neurokinin B (NKB), and dynorphin (KNDy neurons) are 
steroid-sensitive and have been postulated to both generate GnRH pulses and 
mediate steroid feedback on pulse frequency. KNDy neurons are proposed to 
interact with one another via NKB and dynorphin to activate and inhibit the KNDy 
network, respectively, and thus alter kisspeptin output to GnRH neurons. To test 
the roles of NKB and dynorphin on KNDy neurons and the steroid sensitivity of 
these actions, targeted extracellular recordings were made of Tac2(NKB)-GFP-
identified neurons from castrate and intact male mice. Single-cell PCR confirmed 
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most of these cells had a KNDy phenotype. The neurokinin 3 receptor (NK3R) 
agonist senktide increased action potential firing activity of KNDy neurons. 
Dynorphin reduced spontaneous KNDy neuron activity, but antagonism of κ-
opioid receptors (KOR) failed to induce firing activity in quiescent KNDy neurons. 
Senktide-induced activation was greater in KNDy neurons from castrate mice, 
whereas dynorphin-induced suppression was greater in KNDy neurons from 
intact mice. Interactions of dynorphin with senktide-induced activity were more 
complex; dynorphin treatment after senktide had no consistent inhibitory effect, 
whereas pretreatment with dynorphin only decreased senktide-induced activity in 
KNDy neurons from intact but not castrate mice. These data suggest dynorphin-
mediated inhibition of senktide-induced activity requires gonadal steroid 
feedback. Together, these observations support the hypotheses that activation of 
NK3R and KOR, respectively, excites and inhibits KNDy neurons and that 
gonadal steroids modulate these effects. 
 
 
2.2 Introduction 
GnRH neurons form the final common pathway for the central regulation 
of fertility. GnRH is secreted in a pulsatile pattern (4,156-159) that is essential for 
pituitary synthesis and release of LH and FSH (29,33,159-161), which activate 
steroidogenesis and gametogenesis. Although gonadal steroids feed back to 
regulate GnRH pulse pattern (7), detection of steroid receptors other than 
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estrogen receptor β is rare in native GnRH neurons (9,10,162,163), suggesting 
feedback is largely mediated via steroid-sensitive afferents (11,164). 
One steroid-sensitive afferent population is the arcuate neurons 
coexpressing kisspeptin, neurokinin B (NKB, aka Tac2), and dynorphin (KNDy 
neurons (18,19,69,88,119,127,128,131,134)). Several studies suggest these 
cells are important in reproductive neuroendocrine regulation; mutations in the 
kisspeptin receptor KISS1R, NKB, or the NKB receptor NK3R cause 
hypogonadotropic hypogonadism in humans (45,46,122), and knock out of the 
genes for kisspeptin (Kiss1) or KISS1R (Kiss1r) reduce or eliminate reproduction 
in mice (47,48). Furthermore, κ-opioid receptor (KOR, the dynorphin receptor) 
antagonists increase LH release (124). 
KNDy neurons have been hypothesized to regulate the pattern of GnRH 
release as a self-activating and self-inhibiting network (120,131). In this model, 
kisspeptin provides excitatory KNDy network output to GnRH neurons, which 
express Kiss1r (52,53,55,60,62,78,165). NKB is postulated to stimulate KNDy 
neurons (122,132,140), generating kisspeptin release onto GnRH neurons to 
initiate a pulse of GnRH secretion (131,136). NKB-induced activation of the 
KNDy network also putatively activates dynorphin release, and subsequent 
action of dynorphin is proposed to inhibit NKB-stimulated KNDy activation, stop 
kisspeptin output to GnRH neurons, and thus terminate the GnRH pulse 
(120,124,131,149). 
Functional studies of KNDy neurons are limited but have provided initial 
support for some elements of this model (124,166,167). Animal studies using the 
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NK3R agonist senktide, however, have produced variable results, with both 
increases and decreases in LH depending on steroid milieu and species 
(102,120,125,136,138,139,166,168-170). The present study examined how NKB 
and dynorphin interact to alter the activity of GFP-identified KNDy neurons in the 
arcuate nucleus from castrate and intact adult male mice directly at the central 
level. 
 
 
2.3 Materials and methods 
Animals 
Tac2-enhanced green fluorescent protein (GFP) BAC transgenic mice 
[015495-UCD/ STOCK Tg (Tac2-EGFP)381Gsat] were obtained from Mouse 
Mutant Regional Resource Center (http://www.mmrrc.org/). GnRH-GFP mice 
(171) were propagated in our colony. Mice were maintained under a 14h 
light:10h dark photoperiod with 2916 chow (Harlan, Indianapolis, IN) and water 
available ad libitum. Male mice age 38-120d were either left intact or were 
castrated under isoflurane anesthesia 3-7d before study; bupivacaine was 
provided as an analgesic. All procedures were approved by the University 
Committee on the Use and Care of Animals at the University of Michigan. 
 
Brain slice preparation 
Reagents were purchased from Sigma Chemical Company (St. Louis, 
MO) unless noted. Solutions were bubbled with 95%O2, 5%CO2 throughout 
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experiments and for ≥15 min before use. Brain slices were prepared with 
modifications (172) as previously described (173). Brains were rapidly removed 
and placed in ice-cold high-sucrose saline solution containing (in mM) 250 
sucrose, 3.5 KCl, 26 NaHCO3, 10 D-glucose, 1.25 Na2HPO4, 1.2 MgSO4, and 3.8 
MgCl2. Coronal (300µm) slices were cut with a Vibratome 3000 (Ted Pella, Inc., 
Redding, CA). Slices were incubated 30min at 30-32C in 50% high-sucrose 
saline and 50% artificial cerebrospinal fluid (ACSF) containing (in mM) 135 NaCl, 
3.5 KCl, 26 NaHCO3, 10 D-glucose, 1.25 Na2HPO4, 1.2 MgSO4, 2.5 CaCl2 (pH 
7.4), then transferred to 100% ACSF solution at room temperature for 0.5-7h 
before recording. 
 
Cell Harvest for single-cell PCR and cDNA synthesis  
Patch pipettes (2-3MΩ) were filled with 5-8µl of a solution containing (in 
mM): 140 K gluconate, 5 KCl, 10 HEPES, 5 EGTA, 4.0 MgATP, 0.4 NaGTP, 1.0 
CaCl2, pH 7.3, 305 mOsm. The whole-cell configuration was obtained and 
cytoplasm aspirated into the pipette. Pipette contents were expelled into a 
microcentrifuge tube containing 2X reverse transcription buffer, and volume 
adjusted to 20µl with molecular grade water (Invitrogen, Carsbad, California). 
Similarly-prepared pipettes (n=5) were lowered into the slice but positive 
pressure was maintained and no cell contents were intentionally harvested; these 
false harvests were processed as above and used to estimate background 
contamination (174). The components for the reverse transcription reaction were 
(in mM): 20 Tris (pH 8.4), 50 KCl, 5 MgCl2, 10 DTT, 10 dNTPs, plus 500ng oligo 
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dT (Invitrogen), 50ng random hexamers (Roche Life Sciences, Indianapolis, 
Indiana), 200U Superscript III (Invitrogen), and 40U RNase inhibitor (Roche). 
Mouse hypothalamic and liver RNA (10ng diluted in pipette solution) and pipette 
solution stock were also reverse transcribed as positive and negative controls, 
respectively. Additionally, a standard curve of mouse hypothalamic RNA (5, 0.5, 
0.05, 0.005ng/µl final concentration) was reverse transcribed. cDNA synthesis 
was performed as recommended. cDNA was stored at -80C until PCR reactions. 
 
Single-Cell PCR  
Single-cell cDNA, controls and the standard curve were preamplified using 
TaqMan PreAmp Master Mix (Invitrogen). TaqMan PrimeTime qPCR assays for 
mRNAs of Gapdh, Tac2, Kiss1, Pdyn, Oprk1, and Tac3r were purchased from 
Integrative DNA Technologies (Coralville, IA, Table 2.1). All assay primers span 
an intron to minimize amplification of genomic DNA. PrimeTime qPCR assays 
were reconstituted to 20X (5µM probe, 10µM each primer) in Tris-EDTA. The 
components for the preamplification reaction were: 5µl cDNA, 0.05X final 
concentration of each primer-probe, 10µl 2X preamplification buffer and water to 
a final volume of 20µl. cDNA was preamplified for 18 cycles according to the 
manufacturer’s recommended cycling conditions. The preamplified DNAs were 
then diluted 1:10 with Tris-EDTA; a second dilution to 1:50 was also created for 
more abundant transcripts (Gapdh, Tac2), both were stored at -20C until used for 
quantitative PCR. 
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Table 2.1 qPCR assays for single-cell PCR 
gene IDT Assay ID ref seq # exons amplicon (bp) 
amplicon 
location (bp) 
Kiss1 Mm.PT.45.16269514 NM_178260 1-2 105 66-170 
Pdyn Mm.PT.45.9486062 NM_018863 1-2 100 89-188 
Oprk1 Mm.PT.42.8829407 NM_001204371, v1 
NM_011011, v2 
2-3 
2a-3 
94 
94 
398-491 
368-461 
Tacr3 Mm.PT.51.8434948 NM_021382 4-5 114 1266-1379 
Gapdh Mm.PT.39.1 NM_008084 2-3 150 50-199 
PrimeTime® qPCR Assays from Integrated DNA Technologies, Coralville, IA. 
www.idtdna.com/pages/products/gene-expression/primetime-qpcr-assays-and-primers 
 
Quantitative PCR was performed utilizing 2-5µl of diluted preamplified 
DNA per reaction, in duplicate, for 40-50 cycles (TaqMan Gene Expression 
Master Mix; Invitrogen). PCR reaction efficiencies were calculated from the slope 
of the standard curve. To confirm the linearity and parallelism of the 
preamplification step, 2µl of non-preamplified standard curve cDNA was also 
amplified in singlicate. On average, the threshold cycle for preamplified 
standards was 10 cycles earlier than cDNA, but PCR efficiencies were nearly 
identical, indicating cDNAs were amplified linearly and without bias. Single cells 
were considered positive for a transcript if their threshold was a minimum of 4 
cycles earlier than the preamplification blank. Amplicon size was confirmed by 
agarose gel electrophoresis. 
 
Electrophysiological recordings 
Targeted single-unit extracellular recordings were used, as this 
configuration has minimal impact on the cell’s intrinsic properties, including 
response to fast synaptic transmission (175,176). Recording pipettes (1.5-3MΩ) 
were pulled from borosilicate glass (Schott #8250, World Precision Instruments, 
Sarasota, FL) with a P-97 puller (Sutter Instrument, Novato, CA). Pipettes were 
 30  
filled with HEPES-buffered solution containing (in mM): 150 NaCl, 10 HEPES, 10 
glucose, 2.5 CaCl2, 1.3 MgCl2, 3.5 KCl, and low-resistance (23±3MΩ) seals were 
formed between the pipette and neuron. Recordings were made in voltage-clamp 
with a 0mV pipette holding potential and signals filtered at 10kHz using an EPC8 
amplifier and PatchMaster software (v2x42, HEKA Instruments Inc., Bellmore, 
NY). 
 
Experimental designs 
Slices were transferred to a recording chamber with constant perfusion of 
ACSF at 28-33C. All treatments were diluted in ACSF and administered by bath; 
vehicles had no effect on firing rate. After a ≥5min stabilization period, neuronal 
activity was recorded under control and treatment conditions as detailed below. 
At the end of each experiment, inactive cells were treated with high-potassium 
ACSF (20mM K+); cells that exhibited action currents in response were verified to 
be alive and all data, including quiescence, were used; for cells not responding to 
K+, data analysis was truncated at the last action current. 
 
Experiment 1 
To study effects of NKB on KNDy neurons and if steroid milieu modifies 
effects, the NK3R agonist senktide (Phoenix Pharmaceuticals, Inc., Burlingame, 
CA, in ≤0.1% dimethyl sulfoxide) was bath-applied to brain slices from castrate 
(1, 10, or 100nM) or intact adult male mice (10 or 100nM) for 5-7min. Senktide 
was used because it is more specific for NK3R than NKB (177); preliminary 
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studies indicated senktide has similar effects to NKB in KNDy neurons (n=3 cells 
from each castrate and intact males, not shown). Effects of 10nM senktide on 
GnRH neurons from castrate males were also determined and compared to 
untreated GnRH neurons. 
 
Experiment 2 
To examine if activation of NK3R in KNDy neurons from castrate males 
requires fast synaptic transmission, ionotropic GABA and glutamate receptors 
were blocked. Cells were first treated with 10nM senktide as above to verify 
response. In preliminary trials, repeated treatment of the same cell with 10nM 
senktide generated comparable responses under control conditions in KNDy 
neurons from both castrate and intact mice (n=3 each, not shown). Following 
washout (5-30min to allow for return towards basal firing rate), a cocktail of 
blockers of GABAA (100μM picrotoxin in 0.2% ethanol), α-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid (40µM CNQX, 6-cyano-7-nitroquinoxaline-2,3-
dione in 0.2% dimethyl sulfoxide), and N-methyl-D-aspartic acid (20µM APV, 
D(−)2-amino-5-phosphonovaleric acid) receptors was applied for 5min before a 
second 5-7min treatment with 10nM senktide in the blocker cocktail. 
 
Experiment 3 
To study effects of dynorphin on KNDy neurons, 1μM dynorphin A 
(dynorphin, Tocris Bioscience, Ellisville, MO) was applied for 5min to 
spontaneously-active KNDy neurons from castrate and intact males. 
 32  
Spontaneously-active neurons were used because we hypothesized dynorphin 
would inhibit KNDy neurons. Since extracellular recordings monitor firing activity, 
inhibition cannot be observed with this method in quiescent cells. 
 
Experiment 4 
To test the hypothesis that dynorphin reduces senktide-induced KNDy 
neuron activation in castrate males, senktide was applied for 5-7min, followed by 
senktide alone, senktide and dynorphin (1μM), or senktide and the KOR agonist 
U69593 (1μM, in 0.01% ethanol) for an additional 5-7min. To test if endogenous 
KOR activation affected the firing pattern in the presence of prolonged senktide, 
cells were treated for 10min with senktide and a KOR antagonist nor-
binaltorphimine (norBNI, 10µM, Tocris Bioscience). To determine if pretreatment 
with dynorphin blocked the ability of senktide to activate KNDy neurons, senktide 
was applied to confirm responsiveness (as in Experiment 2), and then after the 
wash period 1µM dynorphin was applied for 5min, followed by 5min of dynorphin 
plus 10nM senktide. 
 
Experiment 5 
To test the hypothesis that quiescent KNDy neurons are under 
suppression by endogenous dynorphin, 10µM norBNI was applied to quiescent 
KNDy neurons for 5-6min. The ability of 10µM norBNI to block 1µM dynorphin-
induced inhibition of firing was tested as a positive control. 
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Analyses  
Targeted extracellular recordings detect action currents, which are the 
currents underlying action potentials. Thus their frequency reflects action 
potential firing rate. Action currents were identified using custom software written 
in IgorPro (WaveMetrics, Inc., Lake Oswego, OR). Control action current 
frequency was averaged for the last 2min before treatment. The first 3min of 
treatment were not included in the analysis to allow time for solution exchange 
and drug penetration of the slice; the action current firing frequency was 
averaged during min 4 and 5 after initiating treatment. Cells with basal firing 
frequency ≤0.1Hz were considered quiescent. Cells that remained quiescent 
during treatment were considered non-responsive if they subsequently generated 
action currents in response to elevated K+. Spontaneously-active cells with a 
change in firing frequency of >20% were considered responsive. The percentage 
of responsive cells is reported, but for statistical rigor both responsive and non-
responsive cells were included in statistical analyses. No more than three cells 
from a given animal were included in the same experiment, and n indicates 
number of cells. 
Data are reported as mean±SEM. Non-parametric or parametric two-tailed 
comparisons were utilized as appropriate for data distribution. Responses to 
single treatments were analyzed by Wilcoxon matched pairs test or paired t-test. 
Data from cells exposed to multiple treatments were analyzed by one-way 
Friedman test, followed by a Dunn’s multiple-comparison test. Comparisons 
among groups were analyzed by Friedman two-way repeated-measures analysis 
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of variance, Mann-Whitney, or by unpaired t-test. All tests were two-tailed, 
significance was set at p<0.05. 
 
 
2.4 Results 
GFP expression driven by the Tac2 promoter identifies KNDy neurons in the 
arcuate nucleus 
Single-cell PCR was performed on Tac2-GFP-identified cells from the 
arcuate nucleus of castrate (23 cells) and intact (18 cells) males (Table 2.2). 
Single-cell cDNA was amplified for Gapdh to determine RNA quality; of 41 cells, 
3 did not amplify for Gapdh and were eliminated from further analysis. No 
transcripts of interest were amplified from false harvests (n=5). Tac2 mRNA was 
detected in 87% of all GFP-identified cells, indicating that GFP expression is 
highly correlated with endogenous Tac2 expression. The half-life of eGFP protein 
is ~26h (178). It is thus likely that GFP-identified cells in intact males not 
expressing Tac2 mRNA when harvested had expressed this mRNA within the 
previous few days. All cells from castrate and 71% of cells from intact mice 
expressed Tac2, indicating steroid negative feedback suppresses Tac2 
expression, consistent with earlier reports (120,166,179,180). Consistent with 
this, 16/17 Tac2-GFP-identified cells from intact mice expressed either kisspeptin 
(Kiss1) or prodynorphin (Pdyn) mRNA, indicating a KNDy phenotype (120,166). 
In contrast to a previous report (166), a substantial population of Tac2-GFP 
neurons that did not express Kiss1 was not observed (18% intact mice, 0% 
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castrate mice). This discrepancy may be due to relative sensitivity of methods 
utilized, or the mode of cell identification. The percentage of Pdyn mRNA positive 
cells was 90% in castrate and 76% in intact mice. With regard to G-protein 
coupled receptors, 19% of cells from castrate and 41% of cells from intact mice 
expressed transcript for the dynorphin receptor KOR (Oprk1). Most (86%) cells 
from castrate mice expressed mRNA for the NKB receptor NK3R (Tac3r) vs. 
35% of cells from intact mice. 
Table 2.2 Single-cell PCR results 
 intact 
(n=17) 
castrate 
(n=21) 
transcript 
# cells 
expressing 
transcript 
# cells 
expressing 
transcript 
Tac2 12 (71%) 21 (100%) 
Kiss1 14 (82%) 21 (100%) 
Pdyn 13 (76%) 19 (90%) 
Tac2 + 
Kiss1 
11 (65%) 21 (100%) 
Tac2 + Pdyn 10 (59%) 19 (90%) 
Pdyn + 
Kiss1 
11 (65%) 19 (90%) 
Tac2+Kiss1
+Pdyn 
10 (59%) 19 (90%) 
Kiss1 OR 
Pdyn 
16 (94%) 21 (100%) 
Oprk1 7 (41%) 4 (19%) 
Tac3r 6 (35%) 18 (86%) 
Number of cells expressing transcript (percent GFP-identified cells) 
 
Spontaneous activity of KNDy neurons from intact and castrate males  
Eighty percent of KNDy neurons from castrate mice (78/98) were 
quiescent during the control period (defined as a firing frequency of ≤ 0.1 Hz), 
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whereas 57% (25/44) of KNDy neurons from intact mice were quiescent. The 
firing rate of spontaneously-active KNDy neurons was not different between 
castrate (2.0±0.3Hz, n=20 cells) and intact mice (1.9±0.5Hz, n=19 cells). 
 
The NK3R agonist senktide increases activity to a greater extent in KNDy 
neurons from castrate than those from intact males 
To study the effects of activation of NK3R on KNDy neurons, the NK3R 
agonist senktide was bath-applied to brain slices from castrate adult males 
during extracellular recordings. Figure 2.1A shows a representative response to 
10nM senktide in cells from castrate males. Senktide increased the frequency of 
action currents in a dose-dependent manner (1nM, p=0.0625, n=8; 10nM, 
p<0.05, n=11; 100 nM, p<0.05, n=6, Figure 2.1C). The proportion of cells 
responding with >20% change in firing rate also increased with dose (3 of 8 at 
1nM, 10 of 11 at 10nM, and 6 of 6 at 100nM). 
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Figure 2.1 The NK3R agonist senktide 
increases the activity of KNDy neurons 
and does not change firing activity of 
GnRH neurons. A & B. Representative 
extracellular recordings of a KNDy neuron 
from a castrate (A) or an intact (B, trace 
smoothed to reduce baseline drift) mouse 
during control (left) and 10nM senktide 
(right) conditions; variable current 
amplitudes reflect small changes in 
pipette position during the recording and 
do not provide information about changes 
in cell function. C. Action current 
frequency of KNDy neurons during control 
(c) and senktide treatment at doses 
indicated in castrate (left) and intact (right) 
mice. D. Representative extracellular 
recordings of a GnRH neuron from a 
castrate mouse during control (top) and 
10nM senktide (bottom) conditions. E. 
Action current frequency of GnRH 
neurons during control (c) and 10nM 
senktide (SK) treatment. Open circles 
show data from individual cells, filled 
circles show means: lines connect data 
from the same cell. *p<0.05.
 
To test if gonadal steroids affect the response to senktide in KNDy 
neurons, 10 or 100nM senktide was bath-applied to brain slices from intact male 
mice; Figure 2.1B shows a representative response to 10nM senktide. Firing 
frequency increased in all KNDy neurons from intact mice in response to both 
10nM (p<0.05, n=11, Figure 2.1C) and 100nM senktide (p<0.05, n=7, Figure 
2.1C). Senktide (10nM) caused a greater increase in KNDy neuron activity in 
cells from castrate mice versus those from intact mice (p<0.05, Figure 2.1C), 
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whereas the response to 100nM senktide was similar between cells from castrate 
and intact mice (Figure 2.1C). These data indicate that KNDy neurons from both 
castrate and intact mice are stimulated by activation of the NK3R, but that 
neurons from castrate animals are more sensitive. For subsequent senktide 
experiments, 10nM was used because it was the lowest dose tested that 
consistently elicited a response, and this response was different between 
castrate and intact mice. 
 
Senktide does not alter firing of GnRH neurons 
To test if senktide alters GnRH neuron activity, senktide was bath-applied 
to coronal preoptic area brain slices from castrate GnRH-GFP mice. Senktide 
(10nM) had no consistent effect on firing frequency of GnRH neurons (n=10, 
Figure 2.1D, E), with senktide treatment either increasing (n=5), decreasing 
(n=2), or eliciting no change (n=3) in firing frequency. Additionally, we compared 
senktide-treated cells with untreated GnRH neurons recorded for the same 
duration. Changes in firing frequency pattern in the absence of treatment (n=5, 
not shown) were similar to those during senktide treatment. These data support 
the hypothesis that activation of NK3R within a coronal slice through the preoptic 
area does not consistently alter the activity of GnRH neurons at the level of the 
soma. 
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The senktide-induced response in KNDy neurons is independent of fast synaptic 
transmission 
The activation of KNDy neurons by senktide could be direct and/or via 
NK3R-expressing afferents that remain in the brain slice. To begin to differentiate 
between these possibilities, we asked whether the senktide-induced firing activity 
in KNDy neurons required and/or was modulated by fast synaptic transmission. 
Cells were first verified to respond to senktide (10nM), washed with ACSF, and 
then treated a second time with senktide in the presence of blockers of ionotropic 
GABA and glutamate receptors (Figure 2.2). Blocking these receptors after the 
wash period did not alter firing rate of KNDy neurons (0.6±0.4Hz wash vs. 
0.9±0.6Hz blocked, n=8), nor did it alter senktide-induced activity (8.5±2.4Hz 
unblocked vs. 13±3.0Hz blocked, n=8, Figure 2.2). These data suggest activation 
of NK3R excites KNDy neurons by a mechanism that does not require fast 
synaptic transmission. 
 
Figure 2.2 The senktide-induced 
activation of KNDy neurons is 
independent of fast synaptic 
transmission. A. Representative 
extracellular recordings from a cell 
during control and treatment periods. B. 
Action current frequency during various 
treatments. Open circles show data from 
individual cells, filled circles show 
means; lines connect data from the 
same cell, dashed lines indicate a 
variable wash period with ASCF after 
the first senktide treatment; c=control; 
SK=10nM senktide; block=blockers of 
ionotropic GABA and glutamate 
receptors (APV, CNQX, picrotoxin). 
*p<0.05.
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Spontaneous activity of KNDy neurons is inhibited by dynorphin to a greater 
extent in cells from intact than castrate mice 
To test the hypothesis that dynorphin decreases activity of KNDy neurons, 
we first examined spontaneously-active (>0.1Hz) KNDy neurons. Bath-applied 
dynorphin (1µM) decreased the firing frequency in 6/7 cells from castrate mice 
(n=7, p<0.05, Figure 2.3A) and in all cells examined from intact mice (n=6, 
p<0.05, Figure 2.3A). Dynorphin reduced the firing frequency of responsive cells 
from castrate mice by 50% and by 91% in cells from intact mice. The difference 
between the firing rate during dynorphin treatment vs. the control firing frequency 
was greater in KNDy neurons from intact than those from castrate mice (p<0.05, 
Figure 2.3B). The inhibitory effect of dynorphin was blocked by 10µM norBNI, a 
KOR antagonist, in all KNDy neurons from both castrate (4.5±1.1Hz norBNI vs. 
5.5±1.2Hz norBNI+dynorphin, n=5) and intact (1.1±0.6 Hz norBNI vs. 1.5±0.9Hz 
norBNI+dynorphin, n=3) mice. These data indicate endogenous activity of KNDy 
neurons is inhibited by dynorphin via KOR, and this inhibition is more 
pronounced in the presence of gonadal steroids.
 
 
 
 
 
Figure 2.3 Dynorphin attenuates 
spontaneous activity in KNDy neurons. 
A. Action current frequency during 
periods of control and treatment with 
1µM dynorphin in neurons from castrate 
(left) or intact (right) animals. Open 
circles show data from individual cells, 
filled circles show means; lines connect 
data from the same cell; c=control; 
dynA=1µM dynorphin. B. Difference 
between action current frequency during 
treatment and control periods in cells 
from castrate or intact mice. *p<0.05.
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The KOR antagonist norBNI does not induce activity in quiescent KNDy neurons 
Because the majority of KNDy neurons from castrate mice were quiescent during 
the control period, and because dynorphin inhibited spontaneous activity in most 
KNDy neurons, we hypothesized that activity in quiescent cells was inhibited by 
endogenous dynorphin. To test this, quiescent KNDy neurons were treated with 
the KOR antagonist norBNI (10µM). NorBNI did not induce activity (castrate: 
0.0±0.0Hz control vs. 0.0±0.0Hz treated, n=5; intact: 0.0±0.0Hz control vs. 
0.0±0.0Hz treated, n=5). 
 
The pattern of firing activity in KNDy neurons induced by prolonged senktide 
treatment does not change with subsequent addition of KOR agonists in cells 
from castrate mice 
We next tested the hypothesis that senktide-induced KNDy neuron 
activation is inhibited by dynorphin. KNDy neurons from castrate males were 
either treated with 10nM senktide for a full 10min (n=8) or were treated with 
senktide for 5min followed by senktide plus dynorphin (1µM, n=8) or senktide 
plus the KOR agonist U69593 (1µM, n=9) for an additional 5min. Neither 
dynorphin nor U69593 reduced the senktide-induced activation at the end of the 
second 5-min treatment compared with activity at the end of the 10min senktide-
only treatment (Figure 2.4). 
Examination of individual cells treated with dynorphin during the last 5min 
of the 10min senktide treatment reveals that all cells exhibited >20% decrease in 
firing frequency after addition of dynorphin compared to senktide treatment alone 
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(Figure 2.4). In contrast, only a subset of cells (4/8) treated with senktide alone 
for 10min showed >20% decrease in firing frequency during minutes similar time 
periods of recording (Figure 2.4). To test if the decrease in firing frequency in this 
subset of cells is due to senktide-induced dynorphin release, norBNI (10µM) was 
included during a 10min senktide treatment (Figure 2.4). Similar to the 
observations with senktide alone, norBNI failed to maintain firing rate throughout 
the 10min senktide treatment, with 5/9 cells exhibiting >20% decrease in firing 
frequency. 
 
Figure 2.4 Activation of KOR does not reduce ongoing senktide-induced activity in KNDy neurons 
from castrate mice. Action current frequency during various treatments, which are detailed in text. 
Open circles show data from individual cells, filled circles show means; lines connect data from 
the same cell. c=control; SK=10nM senktide, an NK3R agonist; dynA=1µM dynorphin; U69=1µM 
U69593, a KOR agonist; norB=10µM norBNI, a KOR antagonist. *p<0.05. 
 
Pretreatment with dynorphin blocks senktide-induced activation in KNDy neurons 
from intact but not castrate mice 
To test if treatment with dynorphin before, rather than during, senktide 
application is able to block senktide-induced activity, cells from both castrate and 
intact mice were first verified to respond to senktide (10nM), washed with ACSF, 
and then treated with dynorphin (1µM) followed by a second treatment with 
senktide in the presence of dynorphin (Figure 2.5). Senktide treatment increased 
firing frequency of KNDy neurons from castrate mice to the same extent 
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regardless of whether or not dynorphin was present (0.0±0.0Hz control vs. 
18.1±3.0Hz senktide, p<0.05; 2.1±1.2Hz dynorphin vs. 13.4±2.8Hz 
senktide+dynorphin, p<0.05, n=7, Figure 2.5). In contrast, pretreatment with 
dynorphin decreased the senktide-induced firing frequency in KNDy neurons 
from intact mice (0.0±0.0Hz control vs. 7.2±2.9Hz senktide, p<0.05; 0.0±0.0Hz 
dynorphin vs. 1.2±0.8Hz senktide+dynorphin, n=6, Figure 2.5). Spontaneous 
activity was suppressed in KNDy neurons (n=2 castrate, n=2 intact, not shown) 
throughout a 10-min treatment with dynorphin alone, confirming cells remained 
responsive to dynorphin throughout the duration tested. These data provide 
further support for enhancement of dynorphin-mediated inhibition by gonadal 
steroids.
 
 
Figure 2.5 Pretreatment with dynorphin A decreases 
senktide-induced activity in KNDy neurons from intact 
but not castrate mice. Action current frequency in 
KNDy neurons from castrate (left) or intact (right) 
animals during treatments with 1µM dynorphin (dynA) 
and dynorphin plus 10nM senktide (SK); treatments 
shown follow a previous treatment to confirm 
responsiveness to senktide (not shown). Open circles 
show data from individual cells, filled circles show 
means; lines connect data from the same cell. 
*p<0.05.
 
2.5 Discussion 
Targeted extracellular recordings revealed that the NK3R agonist senktide 
activates KNDy neurons by a mechanism that is independent of fast synaptic 
transmission and is attenuated in cells from intact compared to castrate males. In 
contrast, dynorphin inhibited spontaneous and senktide-induced activity of KNDy 
neurons to a greater extent in cells from intact than castrate mice. 
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Based on genetics studies in infertile patients (122) and the coexpression 
of NKB and NK3R in arcuate neurons (132,140), NKB has joined kisspeptin as a 
focus of studies of afferent control of GnRH release. Unlike the effect of 
kisspeptin, which consistently activates GnRH neurons, studies have yielded 
conflicting results concerning the role and site of NKB action. Peaks of multi-unit 
activity (MUA) recorded near the arcuate nucleus in the medial basal 
hypothalamus are highly correlated with LH pulses, an indirect marker of GnRH 
release. Senktide increased the frequency of MUA peaks in multiple steroid 
milieux (102). In castrate and gonad-intact male nonhuman primates and in 
follicular-phase but not luteal-phase ewes, activation of NK3R caused robust 
single discharges of LH (136,168). These data support a stimulatory role of NKB 
in several steroid conditions. 
Rodent studies have had less consistent outcomes. 
Intracerebroventricular (icv) treatment with senktide decreased serum LH in 
ovariectomized (OVX) mice (120) and rats (125,169) and in OVX rats replaced 
with estradiol in a model of negative feedback (139,169,170). Senktide (icv) also 
decreased the frequency of MUA peaks in OVX rats (169). In contrast, senktide 
(icv) increased serum LH in intact female rats and OVX female rats replaced with 
estradiol (AM vs. PM not indicated) (125). In intact males, senktide (icv) was 
reported to have either no effect (138) or to increase serum LH (166). The lack of 
consistent changes in LH in response to senktide even within a species, sex, or 
steroid model may be due to differences in response at many levels including the 
KNDy neuron, the GnRH neuron, and/or the pituitary. 
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To avoid the complexities of these intermediate systems influencing the 
response to activation of NK3R, we examined the response to senktide directly at 
KNDy or GnRH neurons using electrophysiology to record activity at the soma of 
these cells in acute brain slices from the male mouse. Males were chosen for 
study because they are not subject to the variability of steroid feedback that 
occurs during the ovarian cycle in intact females. Further, GnRH pulse 
generation is a feature of both sexes, and in males this is unencumbered by co-
existence of a surge mode of release. While the steroids involved in feedback 
regulation of pulse frequency could differ between sexes, we postulate that many 
core mechanisms of pulse generation itself are shared between males and 
females. Senktide induced a dose-dependent increase in firing rate of KNDy 
neurons from castrate males, but had no effect on GnRH neurons. These data 
are consistent with a recent electrophysiological study of kisspeptin-GFP-
identified neurons in slices from castrate and intact adult male mice (166). The 
present data further identify a role for gonadal steroids in modulating the 
response to senktide, as the activation induced in KNDy neurons from intact 
males was suppressed. This is contrary to the previous study, which found no 
evidence for steroid dependence of NK3R-mediated activation of KNDy neurons 
(166). This discrepancy may be attributable to recording configuration, as the 
previous study used whole-cell recordings, which alter the intracellular milieu 
unlike extracellular recordings. 
One possible mechanism for the reduced response to senktide observed 
in cells from intact males in the present study may be altered expression of 
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NK3R in KNDy neurons. The transcript for NK3R (Tac3r) was expressed in the 
majority of KNDy neurons from castrate animals but in less than a third of those 
from intact animals. Further, a stimulatory effect of NK3R activation may be 
amplified by positive feedback from other KNDy neurons that synapse on the 
recorded cell (119,128,130). 
In addition to possible network effects of NKB from other KNDy neurons, 
KNDy neurons receive other types of inputs, including those from non-KNDy cells 
that may be responsive to senktide. Some connections with such neurons could 
be maintained within the slice preparation, and thus the effects observed may be 
due to action of senktide that is not directly on the neuron targeted for recording. 
One mode of signaling from these putative upstream neurons to KNDy neurons 
is fast synaptic transmission mediated by GABA and glutamate. KNDy neurons 
receive spontaneous GABAergic and glutamatergic transmission (181,182), 
which may arise in part from KNDy neurons themselves because they express 
both the vesicular glutamate transporter 2 (vGLUT-2) (118,135) and glutamic 
acid decarboxylase (GAD), an enzyme involved in GABA synthesis (135). The 
present observations show that NK3R-mediated stimulation of KNDy neurons is 
independent of fast synaptic transmission mediated by ionotropic glutamatergic 
and GABAergic signaling. 
Gonadal steroids may have an effect on spontaneous activity in KNDy 
neurons. Eighty percent of cells from castrate mice vs. 57% of those from intact 
mice were quiescent. The latter is similar to that observed in whole-cell 
recordings of arcuate kisspeptin neurons from intact males (182). Previous 
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extracellular recordings of these neurons from intact males, however, reported 
only 10% were silent (183). This contrast may in part be due to a different 
definition of quiescence. Specifically, the present study considered cells to be 
quiescent if spontaneous firing frequency was <0.1 Hz, whereas the previous 
extracellular study only considered cells to be silent if the cell did not fire a single 
action potential throughout the recording duration, which would reduce the 
percentage of silent cells. Regardless, all datasets appear to challenge the 
hypothesis that gonadal steroids inhibit endogenous activity in KNDy neurons. It 
is important to point out that the present experiments were designed to examine 
the effects of neuromodulators on firing activity; recordings were thus of short 
duration. Changes in long-term firing pattern relevant to the frequency of GnRH 
release may well reveal effects of steroid feedback. It is nonetheless interesting 
to speculate that the regulation of mRNA expression and the regulation of firing 
activity by steroids in KNDy neurons may be different. 
A potential cause for the quiescence observed in most KNDy neurons is 
endogenous dynorphin within the slice. Antagonists of KOR, the high-affinity 
receptor for dynorphin, support an inhibitory effect of dynorphin on LH release in 
mice, rats, and sheep (120,124,154), and KOR antagonists increase multi-unit 
activity in the medial basal hypothalamus in goats (102). In the present study in 
acutely prepared brain slices, the KOR antagonist norBNI did not initiate activity 
in KNDy neurons from either intact or castrate mice, suggesting that under these 
conditions, endogenous dynorphin is not responsible for quiescence. 
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Unlike the lack of effect of a KOR antagonist on quiescent KNDy neurons, 
the KOR agonist dynorphin inhibited spontaneously-active KNDy neurons. 
Greater inhibition was observed in intact than castrate males, supporting the 
hypothesis that the inhibitory effect of dynorphin on KNDy neurons is greater in 
the presence of gonadal steroids. This may be due to higher responsiveness to 
dynorphin, as single-cell PCR revealed the percentage of KNDy neurons 
expressing KOR in intact mice was twice that in castrate mice in the present 
study. In contrast, in situ hybridization demonstrated no change in the 
percentage of cells expressing the transcript for KOR in castrate vs. 
testosterone-replaced males (166). This discrepancy may result from a difference 
in feedback in intact vs. testosterone-replaced mice or method of mRNA 
detection. 
Dynorphin has been hypothesized to inhibit KNDy neurons after 
stimulation by NKB (120,131,149,169,170). Interestingly, in KNDy neurons from 
castrate males, neither pretreatment with dynorphin nor treatment with dynorphin 
subsequent to senktide treatment altered the average firing frequency pattern 
relative to that of senktide alone. In contrast to KNDy neurons from castrate 
mice, pretreatment with dynorphin attenuated senktide-induced activity in cells 
from intact males. These data further support stronger dynorphin-mediated 
inhibition in the presence of gonadal steroids. The inhibitory effect may be further 
enhanced by the reduced effectiveness of senktide in cells from intact mice. 
Because spontaneous activity in cells from both castrate and intact males was 
reduced by dynorphin, the lack of effect of dynorphin on senktide-induced activity 
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in cells from castrate animals raises the question of what initiates spontaneous 
activity in KNDy neurons, since dynorphin cannot counteract activation of NK3R. 
Other transmitters, such as glutamate or GABA, may play a role in this regard 
(118,135). 
When senktide treatment was extended to ten minutes, some cells 
sustained or increased their firing frequency, whereas others decreased firing 
frequency. This raised the question of whether, in the latter subgroup, senktide 
stimulated release of endogenous dynorphin within the slice, thereby causing 
delayed inhibition of KNDy neuron activity during extended senktide treatment. In 
the presence of the KOR antagonist norBNI, however, a similar subpopulation of 
KNDy neurons decreased firing frequency after activation with senktide. This 
indicates activation of KOR by senktide-stimulated dynorphin release was not 
inhibiting the activity in this subpopulation. These observations suggest 
heterogeneity within the KNDy neuron population, in which some cells become 
desensitized to NK3R activation over time and others do not. 
Disruption of the pulsatile pattern of GnRH release results in infertility in 
diseases including polycystic ovary syndrome and idiopathic hypogonadotropic 
hypogonadism (26,29,184); understanding mechanisms of control of GnRH 
release by steroid feedback is thus crucial to developing treatments. Our work 
begins to elucidate the role of KNDy neurons in this critical role. We provide 
evidence for regulation of KNDy neurons in males by activation of both NK3R 
and KOR in a gonadal steroid-dependent manner, with steroids reducing overall 
activity of KNDy neurons in response to these treatments. The 
 50  
 
electrophysiological recordings presented here used an extracellular 
configuration, which does not interfere with the intracellular environment, but 
does not allow for exploration of intracellular mechanisms. Future work will test 
the mechanisms linking activation of KOR or NK3R to changes in activity. 
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CHAPTER 3 
Both estrogen and androgen modify the response to activation of neurokinin-3 
and κ-opioid receptors in arcuate kisspeptin neurons from male mice
 
The work in this chapter was submitted for review to Endocrinology in August 
2015. 
 
Kristen A. Ruka, Laura L. Burger, and Suzanne M. Moenter 
 
3.1 Abstract 
Gonadal steroids regulate the pulsatile pattern of GnRH that is essential to 
reproduction, but GnRH neurons appear to lack most receptors necessary for 
this steroid feedback. The arcuate kisspeptin, or KNDy (kisspeptin, neurokinin B, 
dynorphin), neuron population may convey steroid feedback to GnRH neurons. 
KNDy neurons increase action potential firing upon activation of neurokinin B 
receptors (neurokinin-3 receptor, NK3R) and decrease firing upon activation of 
dynorphin receptors (κ-opioid receptor, KOR). In KNDy neurons from intact male 
mice, NK3R-mediated stimulation is attenuated and KOR-mediated inhibition 
enhanced compared to castrate mice, suggesting gonadal secretions are 
involved. Estradiol suppresses spontaneous GnRH neuron firing in male mice, 
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but the gonadal secretions that mediate effects on firing in KNDy neurons are 
unknown. To test the effects of gonadal steroids, targeted extracellular 
recordings were made from KNDy neurons in brain slices from castrate adult 
male mice that were treated in vivo with steroid receptor agonists or left 
untreated. Estradiol inhibited spontaneous firing in KNDy neurons; firing rate in 
DHT-treated mice was intermediate between castrate and estradiol-treated mice. 
Both estradiol and DHT, however, suppressed NK3R agonist-induced KNDy 
neuron firing and enhanced the inhibition of firing rate caused by KOR activation. 
An estrogen receptor α agonist but not an estrogen receptor β agonist mimicked 
the effects of estradiol on NK3R activation. These observations suggest 
modulation of responses to activation of NK3R and KOR as mechanisms for 
gonadal steroid negative feedback in KNDy neurons, supporting contribution of 
these neurons to steroid-sensitive elements of a GnRH pulse generator. 
 
 
3.2 Introduction 
GnRH neurons form the final common output from the central nervous 
system that integrates signals from the brain to control reproduction. These 
neurons release GnRH in a pulsatile pattern (4,156,158,159) to stimulate pituitary 
release of LH and FSH, which is essential for reproduction (29). Gonadal steroid 
hormones regulate GnRH pulse patterns (7), but only the β isoform of estrogen 
receptor (ERβ), which is not critical for fertility, has been consistently detected in 
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these cells (10,11,162,163). Steroid-sensitive afferent neurons thus likely convey 
feedback signals to GnRH neurons. 
Several observations support a steroid-sensitive “GnRH pulse generator” 
in the hypothalamic arcuate nucleus (97,102,148,169,185). A likely contributor to 
this pulse generator is the arcuate KNDy neuron population, which is named for 
its colocalization of the neuropeptides kisspeptin, neurokinin B, and dynorphin 
(131). KNDy neurons project to GnRH neurons (131), and all three KNDy 
neuropeptides are important for reproductive function. Mutations in the genes 
encoding kisspeptin receptor, neurokinin B, or the high-affinity receptor for 
neurokinin B (neurokinin-3 receptor, NK3R) have all been found in human 
patients with hypogonadotropic hypogonadism (45,46,122). Consistent with 
these observations, kisspeptin and NK3R agonists increase GnRH neuron 
activity and/or GnRH/LH release (55,62,166,186,187). In contrast, antagonism of 
the high-affinity receptor for dynorphin (κ-opioid receptor, KOR) in mice increases 
LH release (124). 
The neuropeptides made by KNDy neurons also regulate activity of these 
neurons. Activation of NK3R and KOR modifies frequency of action potential 
firing in KNDy neurons (188,189) and these modifications are sensitive to 
gonadal hormones (189). Specifically, NK3R-induced stimulation of action 
potentials is attenuated in KNDy neurons from intact vs. castrate males, whereas 
KOR-mediated inhibition of action potential firing is enhanced in KNDy neurons 
from intact compared to castrate males. Together, these data suggest potential 
mechanisms through which gonadal secretions have a negative feedback effect 
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on KNDy neurons and thus the GnRH pulse generator. However, the identity of 
the gonadal secretions involved remains unclear. 
Estrogens and androgens are both candidate mediators of the feedback 
effects on NK3R and KOR activation in KNDy neurons. KNDy neurons express 
both androgen receptor (AR) and estrogen receptors (19) and may also be 
regulated by steroid-sensitive afferents (190). The brain expresses aromatase, 
which converts testosterone to estradiol (191,192). Both androgens and 
estrogens inhibit arcuate kisspeptin mRNA expression (18,19), but steroidal 
modulation of mRNA expression may not necessarily reflect changes in 
kisspeptin protein levels (193), let alone KNDy neuron action potential firing rate 
and/or downstream GnRH neuron function. In this regard, some studies have 
shown that estradiol is a more potent suppressor of GnRH/LH release in males 
(194-197). To better understand the role of gonadal steroids in the neuropeptide-
mediated stimulation and inhibition of KNDy neurons, the present study tested 
the hypothesis that estradiol is the main steroid modifying action potential firing of 
individual KNDy neurons in male mice. 
 
 
3.3 Materials and methods 
Animals 
Tac2-enhanced GFP BAC transgenic mice (015495-UCD/STOCK Tg 
[Tac2-EGFP]381Gsat) were obtained from the Mouse Mutant Regional Resource 
Center (http://www.mmrrc.org/) and propagated in our colony. Mice were 
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maintained under a 14-hour light, 10-hour dark photoperiod (lights on 3AM EST) 
with 2916 chow (Harlan) and water available ad libitum. Male mice aged 79 to 
123 days were used either intact or following bilateral castration under 
isofluorane anesthesia (VetOne); Bupivacaine (0.25%, 8µl per site, Hospira) was 
provided as a postoperative analgesic. Silastic (Dow Corning) implants 
containing steroids (194) were placed subcutaneously in the scapular region at 
the time of surgery. Mice were used 4-7 days after castration. All procedures 
were approved by the University Committee on the Use and Care of Animals at 
the University of Michigan. 
 
Experimental design 
Reagents were purchased from Sigma Chemical Company unless 
otherwise noted. Intact and castrate (4-7 days post surgery) male mice were 
used. Treatments were administered beginning on the day of surgery. Mice were 
placed in one of six treatment groups: 1) castrate no further treatment, 2) 
castrate plus an implant containing 0.625µg estradiol suspended in sesame oil, 
3) castrate plus two implants containing 400µg DHT each in sesame oil (800µg 
total), 4) castrate plus daily subcutaneous injections of 1mg/kg of the ERα 
agonist 4,4',4''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT; Tocris 
Bioscience), 5) castrate plus daily subcutaneous injections of 1mg/kg of the R 
enantiomer of the ERβ agonist (R)-2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN, 
Tocris Bioscience), or 6) castrate plus daily subcutaneous injections of 2mg/kg 
DPN. All injected treatments were suspended in a vehicle of 5% 
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dimethylsulfoxide (DMSO), 95% sesame oil, administered between 9:30AM and 
12:00PM EST, and terminated the day before recording. All treatments were 
administered in vivo and were not present in recording solutions. 
 
Seminal vesicle mass 
To confirm endocrine status, the ratio of seminal vesicle to body mass was 
determined at the time of brain slice preparation. The ratios from castrate mice 
(2.3±0.2 mg/g, n=20 mice) were lower (p<0.05) than those from intact control 
males (7.0±0.7 mg/g, n=8 mice). Only the group with the DHT implants (8.0±0.4 
mg/g, n=12 mice) had a similar ratio to that from the intact control mice, whereas 
the remaining groups were similar to the castrate mice (PPT, 3.0±0.5 mg/g, n=5 
mice; 1mg DPN/kg, 2.8±0.3 mg/g, n=4 mice; 2mg DPN/kg, 4.0±0.4 mg/g, n=4 
mice). 
 
Determination of estrogen receptor agonist dose 
Groups of castrate or intact adult male mice were treated daily with 
vehicle, PPT, or DPN for 4-6 days. PPT was administered at 1mg/kg (198). DPN 
was administered 1, 2, or 4mg/kg. Injections began the day of surgery, and 
continued until the day before tissue harvest. Agonist concentration was devised 
to give a 50-100µL injection per 25g mouse and volume adjusted by mass. At the 
time of euthanasia, mice were anesthetized under isoflurane and decapitated. 
Pituitaries were collected and RNA extracted via RNeasy (Qiagen). 
Approximately 250ng pituitary RNA was reverse transcribed (20µL/reaction) as 
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described (199) along with a standard curve of mouse pituitary RNA (5, 0.5, 0.05, 
0.005ng/µL final concentration). PrimeTime qPCR assays for mRNAs of prolactin 
(Prl), and the housekeeping genes Ppia, and Rps29 were purchased from 
Integrative DNA Technologies (Table 3.1). Quantitative PCR was performed 
using 10ng cDNA per reaction in duplicate. Relative expression of Prl was 
normalized to the average relative expression of Ppia and Rps29 via the ∆ ∆ Ct 
method. Amplicon size was confirmed by agarose gel electrophoresis. All assay 
primers span an intron to minimize amplification of genomic DNA. PCR reaction 
efficiencies were calculated from the slope of the standard curve. 
Castration reduced pituitary Prl expression and PPT treatment restored 
expression to the same level as that observed in pituitaries from intact animals 
(Supplementary Figure 3.1). While all doses of DPN resulted in reduced (p<0.05) 
pituitary Prl expression compared to intact animals, the highest DPN dose tested 
(4mg/kg) caused higher (p<0.05) Prl expression compared with the castrate 
group (Supplementary Figure 3.1). Based on these findings, only 1 and 2mg/kg 
DPN were tested in electrophysiological experiments. 
Table 3.1 qPCR Assays for PCRa 
Gene IDT Assay ID Accession No. Exons Amplicon, bp 
Amplicon 
Location, bp 
Prl Mm.PT.58.21865636 NM_011164 3-4 142 266-407 
Ppia Mm.PT.39a.2.gs NM_008907 4-5 85 355-439 
Rps29 custom NM_009093 1-2 127 119-245 
Ar Mm.PT.47.17416675 NM_013476 4-5 125 2065-2189 
Esr1 Mm.PT.47.16003033 NM_007956 6-7 100 1456-1555 
Esr2 Mm.PT.47.17681375 NM_207707 4-5 115 1036-1150 
aPrimeTime qPCR assays were from Integrated DNA Technologies, Coralville, Iowa 
(www.idtdna.com/pages/products/gene-expression/primetime-qpcr-assays-and-primers). 
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Cell harvest for cDNA synthesis and single-cell PCR for transcripts of gonadal 
steroid receptors 
Cells used for single-cell PCR were harvested from intact or castrate adult 
male mice as described (189). Briefly, the whole-cell patch-clamp configuration 
was achieved and cytoplasm aspirated into the pipette. False harvests in which a 
pipette was lowered into the tissue but no aspiration of cell contents occurred 
were used to estimate background contamination (174). Additionally, a standard 
curve of mouse hypothalamic RNA (5, 0.5, 0.05, 0.005ng/µL final concentration) 
was reverse transcribed. Single-cell cDNA, controls, and the standard curve were 
preamplified using TaqMan PreAmp Master Mix (Invitrogen) as described (189). 
TaqMan PrimeTime qPCR assays for mRNAs of Ar, Esr1, and Esr2 were 
purchased from Integrative DNA Technologies (Table 3.1). Quantitative PCR was 
performed utilizing 2-5µl of diluted preamplified DNA per reaction, in duplicate, 
for 40-50 cycles (TaqMan Gene Expression Master Mix; Invitrogen). Single cells 
were considered positive for a transcript if their threshold was a minimum of 4 
cycles earlier than the preamplification blank. 
 
Brain slice preparation 
Solutions were bubbled with 95% O2/5% CO2 throughout experiments and 
for ≥15min before use. Brain slices were prepared with modifications (172) as 
described (173). Brains were rapidly removed and placed in ice-cold high-
sucrose saline solution containing (in mM) 250 sucrose, 3.5 KCl, 26 NaHCO3, 10 
d-glucose, 1.25 Na2HPO4, 1.2 MgSO4, and 3.8 MgCl2. Coronal (300μm) slices 
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were cut with a VT1200 S (Leica Biosystems). Slices were incubated 30min at 
room temperature in 50% high-sucrose saline and 50% artificial cerebrospinal 
fluid (ACSF) containing (in mM) 135 NaCl, 3.5 KCl, 26 NaHCO3, 10 d-glucose, 
1.25 Na2HPO4, 1.2 MgSO4, and 2.5 CaCl2 (pH 7.4) and then transferred to 100% 
ACSF solution at room temperature for 1 to 6 hours before recording. 
 
Electrophysiological recordings 
Targeted single-unit extracellular recordings were used because this 
configuration has the least impact on the intrinsic properties of the recorded cell 
(175,176). Recording pipettes (2-4.5 MΩ) were pulled from borosilicate glass 
(Schott 8250; World Precision Instruments) with a P-97 puller (Sutter Instrument). 
Pipettes were filled with HEPES-buffered solution containing (in mM) 150 NaCl, 
10 HEPES, 10 glucose, 2.5 CaCl2, 1.3 MgCl2, and 3.5 KCl, and low-resistance 
(<25 MΩ) seals were formed between the pipette and neuron. Recordings were 
made in voltage clamp with a 0mV pipette holding potential and 2mV/pA gain and 
signals were filtered at 5kHz using an EPC8 amplifier and PatchMaster software 
(version 2x42; HEKA Instruments, Inc). 
Slices were transferred to a recording chamber with constant perfusion of 
ACSF at 29-33C and stabilized for ≥5min before recording from a cell. All acute 
treatments were diluted in ACSF and administered by bath. Vehicles were 
determined to have no effect on firing rate (189). After pipette seal formation and 
another ≥5-min stabilization period, neuron activity was recorded for a 5-min 
untreated control period, followed by 4-5min of treatment. At the end of each 
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experiment, inactive cells were treated with high-potassium ACSF (20mM K+). 
Cells that exhibited action currents in response were verified to be alive, and all 
data, including quiescence, were used. For cells not responding to K+, data 
analysis was truncated at the last action current. 
To test the effect of the in vivo treatments on NK3R-mediated responses 
in quiescent KNDy neurons, the NK3R agonist senktide (10nM, in ≤0.1% DMSO, 
Phoenix Pharmaceuticals, Inc) was bath-applied for 4-5min to brain slices from 
each in vivo treatment group. A cell was considered responsive if it exhibited 
>0.1Hz frequency of action potential firing during senktide treatment. 
To examine the effect of steroid hormones on KOR-mediated responses in 
KNDy neurons, dynorphin A (dynorphin; 1µM; Tocris Bioscience) was bath-
applied for 5min to brain slices from mice treated in vivo with either estradiol or 
DHT. Spontaneously active neurons were used because we hypothesized 
dynorphin would inhibit KNDy neurons. Because extracellular recordings monitor 
firing activity, inhibition of quiescent cells cannot be observed with this method. 
Percent change of firing frequency was used to compare dynorphin responses 
among hormonal treatment groups because of the range of pre-treatment 
spontaneous activity with different hormonal conditions (Figure 3.1). 
 
Analyses 
Results were unaffected by time of day, time from brain slice preparation, 
mouse age, duration of in vivo treatments, and location of the cell within the 
arcuate nucleus. Targeted extracellular recordings detect action currents, which 
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are the currents underlying action potentials. Their frequency thus reflects action 
potential firing rate. Action currents were identified using custom software written 
in IgorPro (WaveMetrics, Inc). Control action current frequency was averaged for 
the last 2min before treatment. The first 3min of treatment were not included in 
the analysis to allow time for solution exchange and drug penetration of the slice. 
Treatment action current firing frequency was determined during the next 2min. 
Cells with basal firing frequency ≤0.1 Hz were considered quiescent. Cells that 
remained quiescent during treatment were considered nonresponsive if they 
subsequently generated action currents in response to elevated K+. 
Spontaneously active cells with a change in firing frequency of >20% were 
considered responsive; quiescent cells that generated action currents at a 
frequency of >0.1Hz during treatment were also considered responsive. The 
percentage of responsive cells is reported, but for statistical rigor, both 
responsive and nonresponsive cells were included in statistical analyses. No 
more than two cells from a given animal and no fewer than four animals were 
included in the same experiment, and n indicates number of cells. 
A subset of cells was not treated because they did not have the firing 
required for an intended experiment (e.g., quiescent vs. active). In these cases, 
the final 1-2min recorded from cells that had stable recordings for ≥5min and 
were verified to be alive were included in analysis of spontaneously-firing vs. 
quiescent cells from different hormonal treatment groups. 
Data are reported as mean ± SEM. Nonparametric or parametric 
comparisons were used as appropriate for data distribution. Responses within 
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groups were analyzed by two-tailed Wilcoxon matched-pairs signed rank test. 
Comparisons among groups were analyzed by Friedman two-way repeated-
measures ANOVA with Bonferroni’s multiple comparisons test (senktide), 
Kruskal-Wallis test with Dunn’s multiple comparisons test (seminal vesicle mass, 
spontaneous firing, percent change with dynorphin), or one-way ANOVA with 
uncorrected Fisher’s least significant difference test (Prl expression). Significance 
was set at p<0.05. 
 
 
3.4 Results 
Spontaneous activity of KNDy neurons differs with in vivo treatment  
Spontaneous firing activity in KNDy neurons in brain slices is an indicator 
of the in vivo influences of treatments through various mechanisms and was 
evaluated for all cells. These data include the control periods of the cells 
presented in the experiments below, as well as stable recordings from cells that 
were not further studied because they did not have the firing rate required for the 
intended experiment. The proportion of cells that were spontaneously active is 
shown in Figure 3.1. Roughly half of the KNDy neurons recorded from the 
castrate (49%, 18/37 cells) and castrate plus DHT-treated (54%, 13/24 cells) 
groups and 38% (9/24) of cells from the estradiol-treated group exhibited 
spontaneous action potential firing (>0.1Hz firing frequency, Figure 3.1 A). 
Estradiol but not DHT lowered spontaneous firing frequency compared to that in 
cells from castrate mice (Figure 3.1 B, p<0.05). These observations suggest that 
 63  
 
estradiol inhibits spontaneous action potential firing rate in KNDy neurons. The 
number of spontaneously firing cells from the other treatment groups was too low 
for statistical comparison (firing rate: PPT 0.3±0.1Hz 2 cells, 1mg/kg DPN 
0.4±0.3Hz 2 cells; 2mg/kg DPN 0.3Hz 1 cell).
 
Figure 3.1 Spontaneous activity in KNDy 
neurons is altered by in vivo treatment. A, 
Spontaneous firing in KNDy neurons from 
the indicated in vivo treatment groups; 
numbers in bars indicate total number of 
cells, % indicates proportion that were 
spontaneously active. B, Action potential 
firing rate in spontaneously-active KNDy 
neurons from indicated in vivo treatment 
groups. Data include control periods of cells 
from experiments below, plus cells that were 
not acutely treated. cas, castrate; E, 
estradiol; PPT, ERα agonist; DPN1, 1mg/kg 
ERβ agonist; DPN2, 2mg/kg ERβ agonist; 
different letters indicate statistical difference, 
p<0.05, Kruskal-Wallis test with Dunn’s 
multiple comparisons test.
 
Both estradiol and DHT attenuate the NK3R-mediated increase in action 
potential firing frequency in KNDy neurons 
To test the hypothesis that estradiol is the main steroid modifying the 
response of KNDy neurons to activation of NK3R, we compared the response in 
castrate adult males left otherwise untreated or treated with estradiol or DHT 
implants. The NK3R agonist senktide (10nM) was bath applied to brain slices 
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during targeted extracellular recordings of quiescent (≤0.1Hz firing frequency) 
KNDy neurons. Representative traces from these recordings are shown in Figure 
3.2 A-C. Senktide increased action potential firing in 100% (6/6) of cells recorded 
from castrate mice, similar to previous reports (189), and senktide increased 
firing in cells from estradiol-treated (70% 7/10 cells) and DHT-treated mice (75% 
6/8 of cells). Both responding and non-responding cells were included for 
statistical analyses. Senktide increased firing frequency (p<0.05 vs. pre-senktide 
control) in castrate and steroid treated mice (Figure 3.2 G). Contrary to our 
hypothesis, this increase in firing frequency was attenuated by either estradiol or 
DHT treatment (both p<0.05 vs. castrate only). 
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Figure 3.2 Estradiol (via ERα) and DHT attenuate the NK3R-induced increase in KNDy neuron 
firing frequency. A-F, Representative raw current traces from KNDy neurons before (left) and 
during (right) acute treatment with the NK3R agonist senktide (10nM) in the various groups as 
labeled. Variable current amplitudes reflect small changes in pipette position during the recording 
and do not provide information about changes in cell function. G, Firing frequency of individual 
KNDy neurons during control period (con) and senktide (SK) treatment. Open circles show data 
from individual cells, filled circles show means, and lines between open circles connect data from 
the same cell; *, p<0.05, comparisons within groups, Wilcoxon matched-pairs signed rank test; #, 
p<0.05, comparisons among groups, Friedman two-way repeated-measures ANOVA with 
Bonferroni’s multiple comparisons test. 
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Estradiol acts via ERα but not ERβ to inhibit the NK3R-mediated response in 
KNDy neurons 
We next tested if ERα or ERβ mediates the suppression of senktide-
induced firing rate. Because mice with kisspeptin-targeted knock out of ERα 
exhibit altered steroid feedback (200), we hypothesized that ERα, not ERβ, 
mediates the estrogen attenuation of the KNDy neuron response to activation of 
NK3R. Senktide was bath applied to brain slices from castrate adult male mice 
that had been treated with daily injections of either the ERα agonist PPT 
(1mg/kg) or the ERβ agonist DPN (1 or 2mg/kg). Representative traces are 
shown in Figure 3.2 D-F. Senktide increased firing frequency (p<0.05 compared 
to pre-senktide control) in cells from both estrogen receptor agonist groups 
(Figure 3.2 G). A response to senktide was observed in 100% of KNDy neurons 
from the groups treated with PPT (7/7) and 1mg/kg DPN (8/8) and in 86% (6/7) of 
cells from animals treated with 2mg/kg DPN. PPT attenuated the senktide-
induced increase in mean firing rate of KNDy neurons (p<0.05 compared to 
castrates). In contrast, DPN had no effect on the senktide-induced increase in 
firing frequency (1mg/kg, p>0.9; 2mg/kg, p>0.9 compared to castrates). 
Together, these data support the hypothesis that ERα mediates estradiol’s 
inhibition of the NK3R-mediated increase in action potential firing in KNDy 
neurons. 
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Both estradiol and DHT enhance the KOR-mediated decrease in action potential 
firing frequency in KNDy neurons 
Dynorphin inhibits KNDy neuron firing activity in a gonad-dependent 
manner, with inhibition being greater in intact than castrate males (189). The 
effect of dynorphin on firing rate of spontaneously-active KNDy neurons from 
castrate male mice treated with estradiol or DHT was examined to test the 
hypothesis that estradiol enhances dynorphin-mediated inhibition of KNDy 
neuron firing rate. Quiescent neurons were excluded from this experiment 
because inhibition of firing could not be observed. Representative traces from 
these recordings are shown in Figure 3.3 A-C. Dynorphin decreased firing (>20% 
decrease in frequency compared with pretreatment spontaneous activity) in 63% 
(5/8) of KNDy neurons from the castrate-only group and in 100% of cells from 
both the estradiol- (9/9) and DHT-treated (7/7) animals. One cell (12.5% of 8 
cells) in the castrate group increased firing frequency (>20% increase compared 
with pretreatment spontaneous activity) during dynorphin treatment. Statistical 
analyses within each in vivo treatment group indicated that dynorphin decreased 
action potential firing within each group (p<0.05 vs. pre-dynorphin control, Figure 
3.3 D). Because of the range of spontaneous firing frequency among groups 
(Figure 3.1), percent change of frequency before and during treatment was used 
to normalize the data for comparison among groups. The percent decrease in 
firing frequency during dynorphin treatment was greater (p<0.05) in cells from 
both estradiol- (92±6% decrease) and DHT- (91±6% decrease) treated mice 
compared to castrates (36±16% decrease). 
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Figure 3.3 Estradiol and DHT enhance the KOR-induced inhibition of KNDy neuron firing 
frequency. A-C, Representative raw current traces from KNDy neurons before (left) and during 
(right) acute treatment with dynorphin (1µM) from the various groups as labeled. D, Firing 
frequency of individual KNDy neurons during control period (con) and dynorphin (dyn) treatment. 
Open circles show data from individual cells, filled circles show means, and lines between open 
circles connect data from the same cell; *, p<0.05, comparisons within groups, Wilcoxon 
matched-pairs signed rank test; #, p<0.05, comparisons among groups (percent change), 
Kruskal-Wallis test with Dunn’s multiple comparisons test. 
 
KNDy neurons from both castrate and intact male mice express AR and/or ERα 
but not ERβ message 
ERβ mRNA (Esr2) expression in KNDy neurons had not been examined in 
male mice. Single-cell PCR was performed on cell contents from fluorescently-
labeled arcuate neurons from intact or castrate Tac2-GFP adult male mice to 
determine expression of Esr2 as well as AR (Ar) and ERα (Esr1) mRNA. GFP 
reliably identifies KNDy neurons in these animals (189). Two cells did not amplify 
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for GAPDH and were thus eliminated from further analysis, leaving 17 cells from 
intact and 22 cells from castrate mice for analysis (Table 3.2). The expression of 
Esr1 and Ar detected by single-cell PCR was consistent with that reported using 
in situ hybridization (19). In contrast, Esr2 was not detected in the cells studied 
from either intact or castrate mice. Of interest, there was considerable overlap of 
Ar and Esr1 expression. Of the cells that expressed Ar, 10 cells (59%) from intact 
and 12 cells (55%) from castrate animals also expressed Esr1. 
 
Table 3.2 Single-Cell PCR Resultsa 
Transcript 
Intact (n=17) 
No. Cells 
Expressing 
Transcript, n (%) 
Castrate (n=22) 
No. Cells 
Expressing 
Transcript, n (%) 
Ar 11 (65) 15 (68) 
Esr1 15 (88) 16 (73) 
Esr2 0 (0) 0 (0) 
Ar + Esr1 10 (59) 12 (55) 
aResults are shown as the number of cells expressing 
transcript (percentage of GFP-identified cells). 
 
 
3.5 Discussion 
Pulsatile GnRH release is controlled by gonadal steroid feedback, but GnRH 
neurons typically lack most receptors critical for this feedback. Here, we show 
that contrary to our hypothesis, agonists of both ERα and AR modify response of 
KNDy neurons to activation of either NK3R or KOR in castrate adult male mice. 
This response is manifested as an attenuation of NK3R-induced stimulation and 
strengthening KOR-mediated inhibition of KNDy neuron action potential firing, 
both of which are consistent with steroid negative feedback to reduce overall 
reproductive neuroendocrine output. 
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Estradiol’s action on the response of KNDy neurons to activation of NK3R 
in males appears to be mediated by ERα. Estradiol-mediated inhibition of the 
NK3R-induced increase in KNDy neuron firing was mimicked by specific agonism 
of ERα but not ERβ. Single-cell PCR identified only ERα, suggesting KNDy 
neurons from male mice may lack ERβ in contrast to these cells in females (18). 
The apparent absence of ERβ in KNDy neurons in males agrees with previous 
work that showed little to no expression of ERβ in the arcuate nucleus of males 
(201-203). It is important to point out that in vivo steroid-induced changes in 
synaptic connectivity or cellular function anywhere within the brain slice could 
alter KNDy neuron activity, thus expression of the receptor within these cells is 
not a prerequisite for response. The present observations are, however, 
consistent with previous studies using global knockouts, which indicated that 
ERα but not ERβ is necessary for fertility in both males and females 
(14,204,205). Likewise, estradiol-induced down regulation of kisspeptin and 
neurokinin B mRNA expression in the female mouse arcuate nucleus is mediated 
via ERα (18,206). Further, kisspeptin-specific ERα knockout advanced pubertal 
onset, disrupted cyclicity, and diminished the ovariectomy-induced increase in LH 
secretion in female mice (200). 
One possible caveat to studies with the ERβ agonist is that we were 
unable to identify a reliable positive control for efficacy of DPN on a putative 
ERβ-specific target (207-210). This was despite using the pure active R-
enantiomer DPN at a molar concentration >3x higher than that of PPT. Our 
strategy was thus to use doses of DPN that did not increase pituitary prolactin 
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mRNA levels, an ERα-specific target, compared to the castrate only group (198). 
DPN has only ~70-fold selectivity for ERβ over ERα, compared with the 400-fold 
selectivity of PPT for ERα (211). Although neither tested dose of DPN attenuated 
the senktide-induced response compared to the castrate-only condition, cells 
from mice treated with the higher DPN dose (2mg/kg) had a distribution of 
senktide-induced responses resembling those of both the estradiol and PPT-
treated groups, in that all of these groups contained a subset of cells with low or 
no response to senktide. Such cells were absent from the castrate and lower 
DPN dose groups. This indicates the 2mg DPN/kg treatment may have some off-
target action on ERα to influence KNDy neuron action potential firing. This was 
also suggested by the small but significant difference between 1 and 2mg 
DPN/kg on pituitary prolactin expression, although neither dose elicited changes 
in prolactin expression compared castrate only. The failure of DPN to alter the 
response to senktide is of interest with regard to the receptor mediating the 
response to DHT. While DHT cannot be aromatized into estradiol, it can be 
metabolized into 5α-androstane-3β,17β-diol, which can act on some isoforms of 
ERβ (212). ERβ-specific agonism did not mimic the effects of DHT, indicating 
DHT action via AR rather than its metabolite’s action on ERβ expressed in other 
neurons that transsynaptically alter KNDy neuron response to senktide. 
In addition to the influence of gonadal steroids on NK3R- and KOR-
mediated responses, estradiol decreased the firing frequency of spontaneously 
active neurons, whereas the spontaneous firing frequency with DHT was 
intermediate to those in the estradiol and castrate-only groups. Previous studies 
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observed no change in spontaneous firing frequency of KNDy neurons between 
castrate and intact male or female mice (183,189). It should be noted that these 
past and the present comparisons were made from short duration recordings and 
may not reflect long-term patterns of activity of these cells. The present data may 
be biased towards spontaneously active neurons as some cells with no 
spontaneous firing activity were excluded from these analyses because 
verification of viability (high K+) was not done to permit subsequent studies on 
other cells in that slice. Despite these possible limitations, the present findings 
suggest that androgens and/or estrogens may influence spontaneous activity of 
KNDy neurons monitored over short duration. 
There are several mechanisms through which estradiol and DHT may 
influence spontaneous KNDy neuron firing activity and/or the response to 
senktide or dynorphin. First, firing activity could be altered by steroid-mediated 
changes in expression or modulation of ion channels and other molecules 
contributing to action potential firing in KNDy neurons. Second, inputs other than 
KNDy neuropeptides, such as fast synaptic transmission, may mediate steroid-
mediated inhibition of KNDy neuron activity (190,213). Third, estradiol and DHT 
may change expression levels of NK3R or KOR. Previous work using single-cell 
PCR found that half as many KNDy neurons from castrate mice expressed KOR 
mRNA and twice as many expressed NK3R mRNA than KNDy neurons from 
intact males (189). This differs from another study in male mice using in situ 
hybridization that found testosterone did not affect the percentage of arcuate 
kisspeptin neurons expressing either receptor message (166). Because these 
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studies focused on mRNA, tests of protein co-localization may ameliorate this 
apparent contradiction. Altered subcellular localization of either NK3R or KOR is 
another possible mechanism for steroid-induced changes in responsiveness. 
Finally, steroids may alter expression of KNDy neuropeptides, as both estradiol 
and DHT suppress arcuate expression of kisspeptin, neurokinin B, and/or 
dynorphin steady-state mRNA levels (18,19,166,206). The present studies 
cannot distinguish among these and other possible mechanisms, leaving this 
area open for further investigation. 
The present study focuses on KNDy neurons, which form an important 
input to GnRH neurons, but steroid feedback likely regulates GnRH release at 
multiple levels in the central nervous system. In this regard, the inhibitory actions 
of both estradiol and androgen at the KNDy neuron are not necessarily reflected 
by GnRH neurons. Inhibition of NK3R-mediated stimulation and enhancement of 
KOR-mediated inhibition in KNDy neurons by both estradiol and DHT would 
presumably decrease the amount of kisspeptin released to stimulate GnRH 
neurons, which express kisspeptin receptor and are directly depolarized by 
kisspeptin (52,53,55,60,61). In a study using the same experimental model used 
here, however, the increase in peaks of action potential firing observed in GnRH 
neurons after castration was inhibited by estradiol whereas DHT had no effect 
(194). Androgens only appear to inhibit GnRH neuron action potential frequency 
in male mice at pharmacologically high doses that mimic steroid abuse (214). 
The contrasting effect of DHT in KNDy vs. GnRH neurons supports past (215) 
and recent (185) evidence that additional central circuits beyond kisspeptin-
 74  
 
expressing neurons alter GnRH output. Estradiol may also have a differential role 
in GnRH neurons via ERβ. Acute treatment with high physiological levels of 
estradiol excites GnRH neurons from female mice via ERβ (11,216). 
A candidate for non-kisspeptin relay of steroid feedback to GnRH neurons 
and for which some mechanistic evidence exists is γ-aminobutyric acid 
(GABA)ergic neurons. GABA excites GnRH neurons because of their intracellular 
chloride concentration (217-219). Estradiol inhibits GABAergic post-synaptic 
currents in GnRH neurons from males (220), consistent with its inhibitory effect 
on action potential firing rate of these cells (194); GABAergic currents in females 
vary with time of day but also correspond directly with changes in GnRH neuron 
firing activity (221,222). Interestingly, estradiol plus DHT increases GABAergic 
currents in GnRH neurons from female mice (223); this combination has not 
been tested in males. One source of GABAergic input to GnRH neurons may be 
KNDy neurons, as half of them coexpress mRNA for glutamic acid 
decarboxylase-67, an enzyme that synthesizes GABA (135). While inhibition of 
KNDy neurons is a plausible pathway to explain estradiol negative feedback via 
reduction of kisspeptin and/or GABA release, it does not account for the apparent 
stimulation of GnRH neurons by estradiol plus DHT. In this regard, there are 
GABAergic inputs to GnRH neurons that are independent of KNDy neurons and 
regulated by other factors (224-228) that may increase excitatory drive to GnRH 
neurons independent of kisspeptin. 
Based on the present observations and previous work highlighted here, 
we propose a model for gonadal steroid feedback on GnRH neurons via KNDy 
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neurons and other inputs (Figure 3.4). In males, estradiol plays an overall 
inhibitory role, attenuating NK3R-mediated stimulation and enhancing KOR-
mediated inhibition of KNDy neuron firing activity. This decreases the amount of 
stimulatory kisspeptin released to GnRH neurons. Estradiol also decreases 
GABAergic excitation of GnRH neurons, ultimately decreasing GnRH release. 
The effects of DHT on NK3R- and KOR-mediated responses in and kisspeptin 
release from KNDy neurons mirror those of estradiol. However, these effects are 
counteracted in the GnRH neuron by a DHT-mediated increase in GABAergic 
excitation, as well as by possible activation of ERβ by the diol metabolite of DHT. 
We propose that in the intact male, the excitatory central effects of androgens 
are outweighed by inhibitory actions of estradiol at the central level, and by 
androgen inhibition at the level of the pituitary (194,229). This is supported by 
high levels of aromatase in the hypothalamus to convert testosterone to estradiol 
(191), as well as the ultimate inhibition of LH release by both estradiol and 
androgen (166,194). 
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Figure 3.4 Proposed model for gonadal steroid feedback on KNDy, GnRH, and other neurons in 
male mice. Different pathways are activated by estradiol (A) and DHT (B) to differentially affect 
GnRH output (see text for details). We propose that in the brain of the intact male, estradiol 
negative feedback prevails. A, The low levels of estradiol in males do not act through ERβ to 
affect GnRH output. B, ERβ may be activated by a diol metabolite of DHT. A star surrounding a 
steroid receptor indicates activation; +, stimulation; -, inhibition. AR, androgen receptor; ERα, 
estrogen receptor α; ERβ, estrogen receptor β; GABAAR, GABAA receptor; Kiss1r, kisspeptin 
receptor; KOR, κ-opioid receptor; NK3R, neurokinin 3 receptor. 
 
The current studies demonstrate an inhibitory role of both estradiol and 
androgen on KNDy neurons via inhibition of action potential firing induced by 
NK3R activation and enhancement of inhibition of firing by KOR activation. These 
findings elucidate in part mechanisms of steroid feedback to a potential key 
component of the GnRH pulse generator. The present data also suggest that 
components beyond kisspeptin neurons are important for the overall regulation of 
GnRH release. 
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3.7 Supplementary material 
 
 
Supplementary Figure 3.1 
Determination of estrogen 
receptor agonist doses.  Fold 
change (compared to intact + 
vehicle) of relative normalized 
expression of prolactin (Prl) 
mRNA, determined by 
quantitative PCR. Vehicle, 
95% sesame oil, 5% DMSO; 
PPT, ERα agonist (1mg/kg); 
DPN, ERβ agonist; different 
letters indicate statistical 
difference; p<0.05, ordinary 
one-way ANOVA with 
uncorrected Fisher’s least 
significant difference test.
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CHAPTER 4 
Conclusion
 
4.1 Contribution of the present work to the KNDy neuron model 
 The work presented in Chapters 2 and 3, as well as other recent studies 
demonstrate that action potential firing in KNDy neurons is stimulated by NK3R 
activation and inhibited by KOR activation (166,188,189,230), and these 
observations support the mechanisms for GnRH pulse initiation and cessation 
proposed in the KNDy model described in Chapter 1. In addition to a potential 
role as a contributor to the GnRH pulse generator, the work presented in this 
dissertation also supports KNDy neurons as mediators of negative gonadal 
steroid feedback. The effects on firing rate of NK3R agonism are attenuated, and 
the effects of KOR agonism are enhanced in KNDy neurons from intact 
compared with castrate male mice (Chapter 2) (189). The gonadal secretions 
mediating these changes appear to be both estradiol via ERα and androgen 
(Chapter 3) (230). Other work initiated since the beginning of this dissertation 
adds further detail to some aspects of the KNDy model while challenging others. 
This work has addressed several questions relevant to KNDy neurons, such as 
their electrophysiological properties, afferents, and output to GnRH neurons. 
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4.2 Electrophysiological mechanisms for modifying KNDy neuron 
activity/output 
 Recent studies have further tested electrophysiological properties of KNDy 
neurons, revealing possible mechanisms for their contribution to pulse generation 
and/or steroid feedback. These studies have characterized nascent pacemaker 
currents, tested membrane current modulation by neuropeptides, and examined 
GABAergic and glutamatergic currents. 
 
Pacemaker currents 
 If KNDy neurons are part of the GnRH pulse generator that controls the 
rate of pulses, then it would stand to reason that they would express pacemaker 
currents that could control periodic bursts of action potential firing. These types of 
currents and the ion channels that carry them have been identified in KNDy 
neurons from female guinea pigs and mice. Specifically, KNDy neurons exhibit a 
hyperpolarization-activated, nonselective cation current (Ih), and to varying 
degrees they express each of the four known subunits of hyperpolarization and 
cyclic nucleotide gated channels (HCN) associated with Ih (167,231). KNDy 
neurons also express mRNA for low-threshold voltage-gated calcium channels 
CaV3.1 and 3.2, and they exhibit the transient (T)-type calcium current (IT) 
mediated by these channels (167). In addition, both α and β subunits of sodium 
channels (NaV) associated with persistent sodium current (INaP) and INaP itself are 
present in KNDy neurons (232). Ih, IT, and INaP all contribute to rhythmic firing and 
burst activity (233-235). Regenerative patterns of action potential firing are not 
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only important for cells, like KNDy neurons, that are hypothesized to maintain a 
rhythmic pace of activity, but burst firing is also critical for release of 
neuropeptides (236-238). Thus, the pacemaker currents may be key components 
of KNDy neurons’ contribution to the GnRH pulse generator by controlling a 
rhythmic pattern of KNDy neuropeptide release. 
 Interestingly, there is not yet evidence that pacemaker currents in KNDy 
neurons play a role in sensitivity to gonadal steroid feedback. While both Ih and IT 
have been found to be regulated by estradiol in other cell types, including GnRH 
neurons (239-241), the response of these currents to gonadal steroids has yet to 
be tested in KNDy neurons. INaP is the only pacemaker current that has been 
tested in this regard, and estradiol affects neither INaP current density nor mRNA 
expression of NaV1.1α or NaVβ2 in KNDy neurons (232). Together these data 
suggest that, although pacemaker currents may contribute to KNDy neuron burst 
firing and neuropeptide release, there are likely other mechanisms through which 
gonadal steroid feedback directly modifies KNDy neuron activity or output. 
 
KNDy neuron membrane currents modified by activation of NK3R and KOR and 
modulation of these currents by gonadal secretions 
One possible site of steroid regulation of KNDy neuron action potential 
firing may be through the pathways stimulated by activation of KNDy 
neuropeptide receptors, in particular NK3R and KOR. However, the mechanisms 
through which activation of NK3R and KOR modify action potential firing in KNDy 
neurons are unknown. In non-hypothalamic cell types, NK3R activation has been 
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linked to various currents including those mediated by sodium, calcium, 
potassium, and non-specific cation channels (242-246). In AVPV kisspeptin 
neurons and other cell types, KOR agonism has been associated with alteration 
of potassium currents possibly via the G-protein coupled inward rectifying 
potassium (GIRK) channel Kir3.1 (247-249). Yet, these types of currents have not 
specifically been tested in KNDy neurons. 
In order to change firing activity in KNDy neurons, we hypothesize that 
activation of NK3R and/or KOR initiates pathways that modulate membrane 
currents to affect action potential firing rate. We further hypothesize that gonadal 
steroids modify these pathways to alter the receptor-modulated membrane 
currents. To begin to test these hypotheses, preliminary whole cell voltage-clamp 
recordings were made of KNDy neurons from intact and castrate male mice. 
Voltage-clamp recordings monitor changes in membrane current. Using a pipette 
solution mimicking the physiological intracellular milieu, we compared membrane 
current and conductance near resting membrane potential at -70 or -60mV under 
control conditions and during treatment with senktide or dynorphin. 
In KNDy neurons from intact and castrate mice, the NK3R agonist 
senktide induced a net inward current, but the current amplitude was markedly 
larger in cells from castrate mice (Figure 4.1). These data are consistent with 
Chapter 2’s observations that the senktide-induced increase in action potential 
firing frequency is greater in cells from castrate mice (189). A relative inward 
current is generated if the net flow, or flux, of positive ions into the cell increases 
with channels opening, or if the net flux of positive ions out of the cell decreases 
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with channels closing (or if net flux of negative ions out of the cell increases with 
channels opening, or if net flux of negative ions into the cell decreases with 
channels closing). An initial gauge of channel opening or closing is provided by 
membrane conductance (inverse of input resistance). Senktide increased input 
resistance (i.e., decreased conductance, Figure 4.1), suggesting NK3R activation 
closed channels. Together, these data indicate decreased conductance via 
channels that, when open, would normally allow net flux of positive ions out of 
the cell (i.e., the net inward current is the result of reducing an outward current). 
Because the membrane potential during the experiment was near the resting 
membrane potential of the cell, the channel would need to be open near this 
potential. Both A- and D-type transient potassium currents (IA and ID, 
respectively), which can be blocked by 4-aminopyridine (4AP), fit this description 
(250,251). 4AP decreased the response to senktide in a cell from a castrate 
mouse (Figure 4.1; for technical reasons the 4AP experiment was done with the 
voltage-gated sodium channel blocker tetrodotoxin, which did not independently 
alter current response, also shown in Figure 4.1), suggesting that senktide acts 
by blocking channels conducting transient potassium currents. In contrast to the 
inward current generated by senktide, dynorphin initiated an outward membrane 
current accompanied by a decrease in input resistance (increase in membrane 
conductance) in a subset of KNDy neurons from intact mice (Figure 4.2). 
Dynorphin’s effect on KNDy neurons from castrate mice has yet to be tested. 
These data demonstrate that intrinsic properties of KNDy neurons can be altered 
by NK3R and KOR activation and that, for at least the former, this response is 
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modulated by gonadal secretions. Modulation of the response to neuropeptides 
therefore remains a major candidate to control KNDy neuron firing, including the 
burst patterns required for release of KNDy neuropeptides. 
 
 
 
Figure 4.1 Senktide induces an inward membrane current (Imem) and increased input resistance 
(Rin) that are attenuated in KNDy neurons from intact vs. castrate male mice. A: Sample Imem 
(closed circles) and Rin (open circles) of KNDy neurons from the indicated treatment groups. Blue 
bars, senktide treatment; TTX, tetrodotoxin, votage-gated sodium channel antagonist; 4AP, 4-
aminopyridine, IA and ID blocker. B: Plots of Imem and Rin measured during the control period (con) 
and senktide (SK) treatment from the groups indicated at the top of “A.” To isolate signals intrinsic 
to the recorded cell, communication within all brain slices was reduced by treatment with blockers 
of receptors mediating fast-synaptic transmission (AMPA-KA, NMDA, and GABAA receptors: 
10μM CNQX, 20μM APV, 100μM picrotoxin, respectively)(220,226). Lines connect data from the 
same cell; points that are the same color in an Imem plot and the Rin plot below it indicate data from 
the same cell; black circles, means; *p<0.05. 
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Figure 4.2 Dynorphin induces an 
outward membrane current (Imem) 
and decreased input resistance (Rin) 
in a subset of KNDy neurons from 
intact male mice. A: Sample Imem 
(closed circles) and Rin (open circles) 
of KNDy neurons that appeared to 
respond (left) or not respond (right) 
to dynorphin treatment (magenta 
bars). B: Plots of Imem and Rin 
measured during the control period 
(con) and dynorphin (dyn) treatment 
from the groups indicated at the top 
of “A.” Lines connect data from the 
same cell; points that are the same 
color in an Imem plot and the Rin plot 
below it indicate data from the same 
cell; black circles, means.
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Figure 4.3 Changes (Δ) in membrane current (Imem) 
and input resistance (Rin) in response to treatment 
from all groups shown in Figures 4.1 and 4.2.
 
GABAergic and glutamatergic currents 
Other mechanisms that may mediate gonadal steroid feedback onto KNDy 
neuron firing are GABA and glutamate. KNDy neurons express ionotropic GABAA 
and glutamate receptors (167,182,231,248,252), and immunocytochemistry 
shows vGlut2-labeled varicosities apposed to the majority of KNDy neurons 
(185). Treatment of rodent arcuate brain slices with the glutamate receptor 
agonist N-methyl-D-aspartate (NMDA) stimulates burst firing in KNDy neurons 
(167,231), supporting activation by glutamate that may be released at the vGlut2-
positive varicosities in vivo. While this study tested exogenous agonism, another 
study in ewes indirectly tested whether glutamate action typically occurs in vivo 
by measuring cFos, an immediate early gene associated with increased firing 
activity. In this study, increased expression of cFos in arcuate glutamate neurons 
is temporally associated with naturally-occurring LH pulses (185), suggesting not 
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only that the arcuate nucleus is capable of exhibiting glutamatergic activity, but 
also that it is correlated with the LH pulse. This observation supports a possible 
non-peptidergic mechanism for pulse generation but does not reveal if this 
mechanism originates from KNDy neurons (131,135) or other glutamatergic 
afferents to KNDy neurons. While stimulation of arcuate glutamate neurons is 
associated with pulsatile LH, neither LH pulse frequency nor amplitude is 
affected by local arcuate microimplantation of an NMDA receptor antagonist in 
vivo (253), suggesting that action via these receptors is not necessary for 
maintenance of LH pulses. Still, the observation with NMDA receptor antagonism 
does not eliminate possible glutamate action via other ionotropic receptors, such 
as AMPA and kainate receptors, or via metabotropic glutamate receptors. 
In terms of GABA, estradiol blunts the frequency and amplitude of 
GABAergic postsynaptic currents in KNDy neurons (182,190), and the change in 
amplitude is mediated by kisspeptin neuron-specific ERα (182). The amplitude 
changes and mediation by ERα support postsynaptic modification of the KNDy 
neuron response to GABA by estradiol, and the changes in frequency suggest 
there are possible pre-synaptic modulations by estradiol, as well. The effect of 
bath-applied GABA is inhibitory to burst firing in KNDy neurons from rodent 
arcuate brain slices (167), but GABA has also been found to depolarize KNDy 
neuron membrane potential (190), an effect traditionally associated with 
activating action potential firing by bringing the membrane closer to firing 
threshold. While these observations appear to contradict one another, the GABA-
induced depolarization is sub-threshold and may be associated with inactivation 
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of ion channels to cause “depolarization inhibition” of KNDy neurons (190). As 
with glutamate, the origin of GABAergic inputs to KNDy neurons may be either 
KNDy neurons themselves (135) or other afferent populations, but these inputs 
have yet to be identified. Together, these observations suggest that both 
GABAergic and glutamatergic inputs to KNDy neurons may influence their ability 
to fire in bursts of activity to release neuropeptides, as well as mediate alterations 
of KNDy neuron firing by gonadal steroids. 
Modification of responses to activation of receptors for neuropeptides and 
amino acids may be key mechanisms for gonadal steroid feedback on action 
potential firing including burst activity. However, the bursts required for 
neuropeptide release act on a scale of seconds, while individual GnRH pulses 
last for minutes and occur at a frequency of minutes to hours. This difference in 
timing indicates that other mechanisms are required to control pulse generation. 
It is possible these mechanisms integrate the electrophysiological properties 
discussed here, perhaps via a coordinated network effect, to achieve the timing 
appropriate for pulse generation. 
 
 
4.3 Afferents to KNDy neurons 
KNDy neuron network 
As discussed in Chapter 1, KNDy neurons are likely inputs for each other 
as part of a putative KNDy neuron network, and recent work has provided more 
support for KNDy neuron fibers within the arcuate nucleus (254-256), as well as 
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bilateral NKB connectivity and synchronized bilateral arcuate electrical activity 
(257). 
 
KNDy neuron network: NKB may act via multiple tachykinin receptors 
Within the KNDy neuron network, new studies have revealed possible 
mechanisms for neurokinin B action besides activating NK3R. While NK3R is the 
highest affinity receptor for NKB, NKB can act with lower affinity on the other 
tachkykinin receptors NK1R and NK2R (258,259). Interestingly, blocking NK1R, 
NK2R, or NK3R alone does not prevent the stimulatory effects of NKB on KNDy 
neuron potential firing, but a cocktail of antagonists for all three tachykinin 
receptors does (188). In terms of mRNA, expression of the message for NK1R 
and NK3R, but not NK2R, is found in at least a subset of KNDy neurons (260). 
NKB may therefore act directly on KNDy neurons via NK1R and NK3R and 
possibly indirectly through NK2R-expressing afferents. 
Besides NKB, the endogenous high-affinity ligands for NK1R and NK2R, 
substance P and neurokinin A, respectively (258,259), may also influence 
reproduction. Intracerebroventricular injection of agonists specific for NK1R or 
NK2R increases LH secretion in male mice and in ovariectomized, estradiol-
replaced female mice. In addition, arcuate expression of the common gene for 
both substance P and neurokinin A (Tac1) is suppressed by estradiol 
replacement in ovariectomized mice (260). Whether the Tac1 mRNA splice 
variants specific to each peptide are differentially affected is unknown. In a test of 
how substance P or neurokinin A affects KNDy neuron membrane potential, an 
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acute localized puff of either peptide depolarizes KNDy neurons in arcuate brain 
slices (188). The treatment paradigm in this test minimizes intercellular 
communication by using tetrodotoxin plus blockade of ionotropic GABA and 
glutamate receptors, suggesting the effects are direct on KNDy neurons rather 
than via afferents. It is unclear, though, whether the observed depolarizations are 
a result of the different tachykinins acting with lower affinity on NK3R or even 
NK1R. If substance P and neurokinin A do affect KNDy neuron activity, the 
sources of substance P and neurokinin A are unlikely to be KNDy neurons 
themselves because Tac1 expression does not overlap with Kiss1 expression in 
the arcuate (260). Furthermore, the physiological significance of activating the 
high affinity receptors for these peptides may be minimal. A peak in arcuate MUA 
accompanied by a pulse of LH release is readily stimulated by intravenous 
treatment of low concentrations of senktide in goats (261), supporting stimulation 
via NK3R. However, agonists for NK1R and NK2R in the same study are only 
able to mimic the responses to senktide in a subset of animals when used in 
concentrations 100x that used for senktide (261). These observations suggest 
that the impact on GnRH pulse generation by NK1R and NK2R activation in 
goats may be limited. Together these data support possible NKB action via all 
three tachykinin receptors to affect KNDy neuron activity. They also suggest that 
substance P and neurokinin A may affect KNDy neurons, but that the impact of 
this action on the reproductive axis may be minimal. 
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KNDy neuron network: Kisspeptin and/or RFRP-3 may modify the KNDy neuron 
network 
 In addition to the influence of NKB and dynorphin on KNDy neuron activity 
supported in Chapters 2 and 3 (189,230), we must consider the possibility that 
the KNDy neuron network is affected by kisspeptin. As discussed in Chapter 1, 
KNDy neurons appear to lack kisspeptin receptor (63), and, not surprisingly, 
kisspeptin has no effect on KNDy neuron action potential firing (188). However, 
several recent studies have forced researchers to revisit the possibility that 
kisspeptin may still play a role in the arcuate nucleus. LH secretion is increased 
by treatment with a kisspeptin agonist targeted to the arcuate nucleus in rats 
(262), and it is suppressed by kisspeptin antagonism targeted to the same 
hypothalamic region in ewes (253), suggesting that the arcuate nucleus may be 
responsive to stimulation by kisspeptin. The kisspeptin receptor agonists and 
antagonists in these studies were administered by localized microimplants or 
microinjections to the arcuate region. Therefore, the area affected by the 
treatment may not be perfectly limited to the arcuate nucleus, and the strategy for 
treatment may damage the targeted tissue. Therefore, other studies are needed 
to further test the possible involvement of kisspeptin in this region. One such 
study uses a kisspeptin receptor knockout mouse, and finds that kisspeptin-
induced changes action potential firing rate are unaltered in unidentified arcuate 
neurons from this knockout mouse (263), suggesting that the effects observed in 
this study as well as those with microimplants and microinjections may be 
independent of the kisspeptin receptor. One possible explanation is that 
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kisspeptin may act through another receptor type, in particular neuropeptide FF 
(NPFF) receptors (264-266), which have been found on KNDy neurons (267). 
NPFF receptors are primarily known for being receptive to RFamide-related 
peptide-3 (RFRP-3), also known as gonadotropin-inhibiting hormone for inhibiting 
gonadotropin release (268,269). RFRP-3 immunoreactive fibers have been found 
in apposition to KNDy neurons (267). Despite opposing effects of kisspeptin and 
RFRP-3 on GnRH release and neuronal excitability (51-53,55,57,199,270-272), 
the effects of these two peptides on electrical activity in unidentified arcuate 
neurons appear to be similar to each other (263). Future work is needed to 
identify whether these arcuate neurons are KNDy neurons or other cell types. 
The proportion of KNDy neurons expressing mRNA for NPFF receptors is not 
changed by gonadectomy in male and female mice, suggesting that the 
availability of these receptors is unaltered by gonadal steroids (267). Still, it has 
yet to be tested whether steroids affect other NPFF receptor-induced factors, 
such as intracellular signaling. While kisspeptin may not act directly on the KNDy 
neuron network, it may act indirectly, and both kisspeptin and RFRP-3 may act 
through NPFF receptor-expressing afferents to influence KNDy neuron activity. 
 
Other inputs to KNDy neurons 
KNDy neuron activity and output may be modulated by other afferents, 
from neuronal areas associated with regulation of fertility regulation as well as 
other functions. Regarding regions of the brain associated with reproduction, 
KNDy neurons may receive inputs from GnRH neurons and AVPV kisspeptin 
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neurons. Tract tracing and immunoreactivity studies have shown GnRH 
varicosities and terminals in apposition to KNDy neurons (273,274), and GnRH 
neurons make asymmetric synaptic contacts with KNDy neurons, suggesting that 
these are excitatory connections (274). LH release is unaffected by GnRH 
antagonism in the arcuate nucleus (253), but the input from GnRH neurons 
indicates that there may be reciprocal communication between GnRH neurons 
and KNDy neurons, perhaps serving to amplify signals initiated by either 
population to affect the other. Another neuronal population linked to reproduction, 
the AVPV kisspeptin population, projects to KNDy neurons (87), suggesting 
possible communication with mechanisms for positive gonadal steroid feedback, 
as well (275,276). 
Other types of inputs to KNDy neurons that have been identified include 
those that relay messages of metabolism and energy balance. Leptin stimulates 
KNDy neurons by activating TRPC channels (231), and cocaine- and 
amphetamine-regulated transcript has been shown to directly stimulate KNDy 
neuron activity (277). KNDy neurons may also receive inputs from pro-
opiomelanocortin and neuropeptide Y neurons (277,278), but whether and how 
these inputs influence KNDy neuron electrical activity or neuropeptide output is 
unknown. It is possible that any of the putative afferents to KNDy neurons, 
including GnRH neurons, AVPV kisspeptin neurons, and other KNDy neurons, as 
well as neuronal populations involved with non-reproductive functions can 
ultimately influence KNDy neuron activity and its influence on the rest of the 
reproductive axis. 
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4.4 KNDy neuron output to GnRH neurons 
 While it is important to consider regulation at the KNDy neuron level, as 
well as inputs to KNDy neurons, it is especially important to consider how 
efferents from KNDy neurons act downstream, particularly in the context of their 
possible contribution to a gonadal steroid-sensitive GnRH pulse generator. There 
is compelling support for KNDy neuron projections to and synapses on GnRH 
neurons (279-281), but the understanding of the locus of KNDy action on GnRH 
neurons has been shifted since the original KNDy neuron hypothesis was 
proposed. Despite the strong stimulation of GnRH neuron firing by kisspeptin that 
was mentioned in Chapter 1 (51-57), studies in both rodents and ungulates have 
found only rare kisspeptin projections to GnRH cell bodies in the POA 
(87,131,255,273,282). Rather, much more evidence has illustrated kisspeptin- 
and/or NKB-expressing fibers projecting to GnRH neuron fibers in the median 
eminence (255,256,273,282-284), suggesting that KNDy neuron action on GnRH 
neurons may be localized mostly to GnRH neuron projections rather than cell 
bodies. 
The limited KNDy connectivity with the GnRH neuron cell bodies does not 
eliminate the relevance of KNDy neurons to the control of GnRH release. Indeed, 
GnRH neuron activity initiated near the soma may not even be necessary for 
GnRH release. One study in ewes found that expression of cFos is increased in 
GnRH neurons by treatment with opioid antagonists, which increases LH 
 94  
 
pulsatility (285). However, in other work that studied naturally-occurring LH 
pulses, cFos expression in GnRH neurons did not increase near the time of a 
natural LH pulse, although cFos did increase in arcuate kisspeptin neurons at 
this time (185). These data suggest via gene expression that an LH pulse may be 
temporally associated with increased firing activity in KNDy neurons, but that this 
increase in activity in KNDy neurons may not necessarily coincide with increased 
activity in GnRH neurons. The output from these more active KNDy neurons may 
elicit GnRH release by acting at the level of GnRH neuron projections, as 
kisspeptin treatment targeted to the median eminence by microinjection elicits a 
pulse of LH (185). This possibility is further supported by measurements of 
GnRH using fast scan cyclic voltammetry (FSCV) in mouse brain slices, which 
find that local kisspeptin treatment can evoke GnRH release in the median 
eminence whether or not action potentials are blocked (187), demonstrating 
kisspeptin-stimulated release of GnRH in the presence and absence of GnRH 
neuron activity. 
Kisspeptin is not necessarily the only KNDy neuropeptide that modulates 
GnRH release; NKB may play a similar role at the median eminence. As 
mentioned in Chapter 1, little to no NK3R has been detected on GnRH neuron 
somata (121,132,140,166), but NK3R immunoreactivity has been found in 
apposition to GnRH nerve fibers in the median eminence (121,140). This 
difference in NK3R expression is reflected by recent functional studies, which 
show that GnRH neuron action potential firing is not altered by senktide or NKB 
(166,189) and that GnRH release measured by FSCV is induced by local 
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senktide treatment to the median eminence (186). Importantly, the senktide-
induced GnRH release is still observable in kisspeptin knockout mice (186). 
Together, these data suggest that NKB can act in the median eminence to evoke 
GnRH release independent of kisspeptin. 
 
 
4.5 Further support and challenges to the KNDy neuron model 
 Besides the observations relevant to the KNDy neuron model that have 
already been discussed, there is additional recent work that either supports or 
contradicts different components of the model. Anatomically, in situ hybridization 
has corroborated coexpression of mRNA for kisspeptin, NKB, and dynorphin in 
the arcuate of male mice (166,189), and immunohistochemistry has confirmed 
that the majority of kisspeptin neurons also express NKB in ewes (286). It should 
be noted, though, that another study using immunoreactivity in the arcuate 
nucleus of male rats found a substantial number of NKB neurons that did not 
colocalize kisspeptin (287), potentially challenging the view of consistent 
colocalization of all three KNDy neuropeptides in the arcuate nucleus of all 
mammals. 
Some studies have also tested the contribution of KNDy neurons to the 
control of gonadotropin levels by using targeted knockdown or ablation of arcuate 
neurons expressing kisspeptin or NK3R in adult rodents (275,288,289). Two of 
the studies knock down arcuate kisspeptin using microinjections of recombinant 
adeno-associated virus encoding a kisspeptin antisense targeted to the arcuate 
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nuclei of adult female rats (275,289). Although these studies only achieve 
roughly 30% decrease of arcuate kisspeptin neurons compared to untreated 
controls, they still demonstrate decreased LH pulse frequency and abnormal 
estrous cyclicity (275,289), suggesting that a fully-intact KNDy population is 
required for the combination of consistently normal LH pulsatility with normal 
cyclicity. Another study achieves high levels (93-98%) of ablation of KNDy 
neurons by injecting an NK3R agonist conjugated to saporin (a ribosome 
inactivating toxin) into the arcuate nuclei of female rats (288). This study does not 
report on cycles, but it does show that KNDy neuron ablation causes overall 
lower serum gonadotropin concentrations (288), further supporting the necessity 
of KNDy neurons to sustain normal gonadotropin levels. These data are 
consistent with an important role for KNDy neurons in normal LH pulsatility and 
overall secretion. 
 In addition to testing their role in pulse generation, recent studies have 
also tested KNDy neurons’ contribution to gonadal steroid feedback. The initially-
hypothesized role in negative feedback was largely based on studies showing 
steroid-mediated downregulation of expression of the genes for KNDy 
neuropeptides (18,19,90,91,93,120,125,126). This effect is corroborated in many 
recent mammalian studies testing mRNA expression for kisspeptin, NKB, and 
dynorphin (166,254,290,291), including the single-cell PCR studies in Chapter 2 
(189). The mechanisms for regulation of the expression of KNDy mRNA were 
largely unknown until two recent studies that revealed that estrogen regulation of 
arcuate kisspeptin expression is mediated by epigenetic mechanisms interacting 
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with the 5’ promoter region of kisspeptin (292,293). Future investigation is 
needed to build on these findings for kisspeptin, as well as to test mechanisms of 
steroid regulation of NKB and dynorphin mRNA expression. 
In further investigation of steroid feedback, a recent tracing study in 
female mice found that all arcuate kisspeptin neurons shown to connect with 
GnRH neurons also express ERα (281). In addition, estradiol is unable to inhibit 
kisspeptin mRNA expression in female mice with kisspeptin-specific ERα 
knockout (294). One of the previously-mentioned ablation studies also examined 
KNDy neurons’ contribution to gonadal steroid feedback. While arcuate NK3R 
cell ablation prevents the rise in LH normally observed with ovariectomy, it does 
not block the inhibitory effects of estradiol on gonadotropin secretion (288). In 
support of this observation, estradiol can still inhibit LH secretion in kisspeptin 
cell-specific knockout of ERα female mice (294). These data suggest that 
negative estradiol feedback to GnRH release can bypass KNDy neurons. 
 There are two major caveats to the conclusions made based on 
kisspeptin-specific knockout of ERα. First, the knockout is effective in these 
animals from the moment the Kiss1 promoter activates Cre recombinase (294), 
leaving open the possibility for compensatory mechanisms to occur throughout 
development. This concern is partially addressed in the arcuate NK3R and 
kisspeptin ablation studies because these are performed after birth during 
adulthood. Yet, these experiments do not study knockout of ERα specifically in 
KNDy neurons. The second caveat is that ERα knockout would indeed affect 
kisspeptin neurons in the arcuate nucleus, but it would also cause ERα knockout 
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in other kisspeptin neurons, including those in the AVPV, making it difficult to 
distinguish effects specifically on the arcuate. Future work could address this 
challenge by utilizing mice with Tac2-specific knockout of ERα (Tac cre x ERα 
floxed; TERKO) produced by the Myers lab. This knockout will affect the arcuate 
kisspeptin population rather than all kisspeptin neurons, as well as a small 
number of cells in other brain regions not typically associated with reproductive 
neuroendocrine function (Greenwald-Yarnell, unpublished). The TERKO mice 
would also help to determine if the ERα-mediated change in the KNDy neuron 
response to NK3R activation shown in Chapter 3 is mediated directly at the 
KNDy neuron or by estrogen-sensitive afferents. Similarly, a Tac2-specific 
knockout of AR would also help to elucidate the locus of action of androgens in 
KNDy neuron responses. 
 
 
4.6 Conclusions and future directions 
 Much of the work discussed here supports KNDy neurons as components 
of the GnRH pulse generator that may also help to relay negative gonadal steroid 
feedback to GnRH release. However, we propose modifications to the KNDy 
neuron model. Much of the evidence still supports an interconnected network of 
KNDy neurons in the arcuate nucleus that is stimulated by NKB and inhibited by 
dynorphin. However, NKB may act by receptors other than NK3R, such as 
NK1R, and dynorphin’s actions may be relatively weak and largely dependent on 
gonadal steroids. In addition, other factors like glutamate, GABA, GnRH, RFRP-
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3, and kisspeptin itself, not to mention inputs from other systems including 
metabolism, may contribute to the ultimate activity and output of KNDy neurons. 
Regarding output, there may only be scarce KNDy neuron projections to GnRH 
neuron cell bodies in the POA, while their biggest impact on GnRH release is at 
the GnRH terminals in the median eminence. It is possible that stimulation of 
GnRH neurons near their projection terminals may initiate action potentials that 
propagate towards the GnRH soma, but the importance of KNDy neurons in 
stimulation of GnRH action potential firing may be minimal. Instead, KNDy 
neuron influence on vesicular release of GnRH may be much more 
physiologically relevant. In addition to kisspeptin, KNDy neurons may also 
release NKB at the median eminence to induce GnRH release. In terms of 
gonadal steroid feedback, evidence still exists for KNDy neurons as partial 
mediators of negative gonadal steroid feedback, in part by modulation of their 
responses to activation of NK3R and KOR. Gonadal steroids may also influence 
endogenous currents in KNDy neurons, as well as KNDy neuron morphology. 
With the modified model in mind, though, KNDy neurons appear to be 
neither the entire GnRH pulse generator nor the only mechanism for negative 
gonadal steroid feedback onto GnRH release. A great deal of work still needs to 
be done to determine exactly how KNDy neurons fit into the larger framework of 
a negative-feedback mediating GnRH pulse generator. While there is support for 
a KNDy network, there is limited evidence for synchronized activity within the 
network. One preliminary study from our lab started to test possible synchrony 
using dual simultaneous long-term extracellular recordings of KNDy neurons in 
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brain slices from adult male mice (295). It found limited synchrony in firing 
between pairs of KNDy neurons (295), contrary to a hypothesized KNDy neuron 
network with coordinated activity. Future studies using similar strategies to record 
multiple KNDy neurons will be needed to expand these data and further test the 
proposed synchrony in firing activity. In addition, if the state of the art permits, the 
relationship, if any, between KNDy neuron firing and the release of 
neurotransmitters and peptides from KNDy neurons needs to be tested. Further 
investigation is also necessary to identify the currents and ion channels relevant 
to KNDy neuron firing patterns and steroidal regulation, particularly those 
affected by activation of NK3R and KOR. 
KNDy neurons appear to interact with other areas of the brain besides 
GnRH neurons and each other (281). Regarding areas directly implicated in 
reproduction, KNDy neurons may project to AVPV kisspeptin neurons and the 
ependymal layer of the third ventricle (256,273). Outside of a direct reproductive 
role, KNDy neurons may also influence POA regions involved in temperature 
regulation (296). In terms of afferents, KNDy neurons may receive inputs from 
neuronal areas implicated in circadian/diurnal rhythms, limbic responses, and, as 
mentioned earlier, energy balance (190,231,277,278,297). Recent studies have 
also suggested that KNDy neurons may even be involved in positive gonadal 
steroid feedback in some species (275,276), emphasizing the need for future 
studies in both females and males. Understanding how all of these systems may 
influence reproduction will require determining how KNDy neurons interact with 
each system and integrating this knowledge to reflect the complexity of the 
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organism as a whole. To achieve this goal, there are many more avenues of 
future work that have yet to be explored. 
 
 
4.7 Impact 
 The work presented in this dissertation advances the field of reproductive 
neuroendocrinology. In particular, it elucidates mechanisms through which KNDy 
neurons may contribute to the GnRH neuron pulse generator as well as mediate 
negative gonadal steroid feedback onto GnRH release. It opens many questions 
for future investigation to study hypothalamic influence on reproductive function.
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